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CHAPTER 1: BACKGROUND AND SIGNIFICANCE
Background of the Study
Chronic Kidney Disease (CKD): Definition, Stages and Prevalence
CKD is a debilitating disease of the kidneys characterized by a gradual loss of kidney
function ranging from months to years. The loss in kidney function is evident from reduction in
the urine production rate from the kidneys, also known as glomerular filtration rate (GFR). CKD
is classified to five stages based on GFR values and the albumin creatinine ratio. These five stages
are shown in Table 1. The last stage of CKD, Stage G5 is also known as End Stage Renal Disease
(ESRD).
Table 1
Stages of CKD
Stage of CKD
G1
G2
G3a
G3b
G4
G5

GFR (ml/minute/1.73m2)
≥ 90
60-89
45-59
30-44
15-29
<15

Note. Adapted from Kidney Disease Statistics for the Unite States, 2016.
GFR-Glomerular filtration rate, ml/minute/1.73m2- milliliters per minute
per 1.73 meters square.

Stage G5 CKD has a GFR of < 15 ml/minute/1.73m2. While Stages G1 to G3 are mostly
asymptomatic, Stages G4 and G5 are the most disturbing stages with innumerable symptoms and
complications (“Kidney Disease Statistics for the United States,” 2016). In Stage G5 CKD, the
individual becomes dependent on various renal replacement therapies including hemodialysis
(HD), peritoneal dialysis (PD) or kidney transplantation to sustain his/her life (Daugirdas, Blake,
& Todd S., 2015).
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CKD affects nearly 31 million people in the US and the most common causes of ESRD
are diabetes and hypertension (“Kidney Disease Statistics for the United States,” 2016). The
prevalence of CKD is 15 percent and there are 726,331 cases of ESRD in the U.S. population
(“Annual Data Report Highlights,” 2018). CKD is the 9th leading cause of death in the US, and
has a high incidence of premature death (“Kidney Disease Statistics for the United States,” 2016).
Almost 63.1% of all patients with ESRD were receiving HD whereas 7% were treated with
PD, and 29.6% had a kidney transplantation (“Annual Data Report Highlights,” 2018). HD therapy
involves filtration of blood across a membrane filter called dialyzer, and the individual is
connected to a machine at a dialysis unit or at home. The blood is filtered across the membrane
and various waste products from a person’s blood shift to the other side of the dialyzer membrane
where dialysate is present. These waste products include urea, creatinine, potassium and extra fluid
that is accumulated in the blood. Individuals on HD must be dialyzed 2 to 3 times weekly to get
rid of the waste products and fluids in their body (Daugirdas et al., 2015).
Fatigue in Stages G4 and G5 CKD
Multiple symptoms are reported by individuals suffering from CKD, particularly in the
advanced stages. Almost 30 symptoms have been reported in individuals with CKD with the
common ones including fatigue (81%), drowsiness (75%), pain (65%), pruritus (61%), and dry
skin (57%) (Almutary, Bonner, & Douglas, 2016). Amongst these symptoms, fatigue is one of the
most bothersome, distressing, troublesome and a major source of stress in the past studies
conducted in individuals with advanced CKD (Almutary, Bonner, & Douglas, 2013; Biniaz,
Tayybi, Nemati, Shermeh, & Ebadi, 2013; Horigan, Schneider, Docherty, & Barroso, 2013; Jhamb
et al., 2013). The reported prevalence of fatigue ranges from 60-97% in individuals with Stage G5
CKD (Horigan, 2012), and 70-97% in Stage G4 and Stage G5 CKD (Bonner, Caltabiano, &
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Berlund, 2013; Bossola, Vulpio, & Tazza, 2011). Almost 56% of individuals on HD reported
suffering from severe fatigue (Bayumi, 2015).
Almost 94% of individuals on HD reported that they would accept more frequent HD if it
would increase their energy, which indicates that fatigue is important to individuals on HD (Jhamb
et al., 2013). In fact, the prevalence of fatigue in dialysis individuals is higher than the general
population (Artom, Moss-Morris, Caskey, & Chilcot, 2014). Investigators found fatigue being
cross loaded on five symptom clusters in Stage G5 CKD individuals that confirms the pervasive
nature of fatigue (Almutary, Douglas, & Bonner, 2016).
Fatigue is a multidimensional and multifactorial concept with poor outcomes that
encompasses an individual’s personal, professional and social life (Ream & Richardson, 1996).
Individuals with CKD describe fatigue as a subjective, unpleasant, distressing experience
associated with generalized feelings of tiredness and exhaustion (Artom et al., 2014). Fatigue is
multidimensional; various aspects such as physical, cognitive and affective components are
involved. In ‘physical fatigue’ there is physical discomfort and the patient feels ‘feeble, dizzy and
tired’ (Lee, Lin, Chaboyer, Chiang, & Hung, 2007) and is exhausted (Horigan et al., 2013).
‘Affective fatigue’ causes emotional reactions like ‘feeling bad’, ‘being upset,’ and ‘cognitive
fatigue’ causes ‘difficulty in paying attention’ or ‘difficulty in keeping eyes open’ and ‘difficult to
concentrate’ (Lee et al., 2007), ‘difficulty in remembering names’ and ‘difficulty in participating
in conversations’ (Horigan et al., 2013). Among all the types of fatigue described above,
individuals on HD in Taiwan reported ‘affective fatigue’ the most (Lee et al., 2007).
Other multidimensional aspects of fatigue include ‘quality,’ ‘distress,’ ‘timing,’ and
‘severity.’ Temporal patterns were studied using a qualitative approach in 14 individuals on HD
over a 36-hour period from one HD session to the evening before the next session. Participants
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reported continuous fatigue and a spike of fatigue after dialysis (Horigan & Barroso, 2016).
Limited research is available on the ‘quality’ of symptom fatigue in individuals with CKD, in that
fatigue has been described by different words such as ‘feeling exhausted,’ ‘weak,’ ‘tired,’ and
having ‘insufficient energy (Lee et al., 2007)’. The ‘severity’ of fatigue has been reported in
various studies that used the Fatigue Severity Scale in individuals on HD, in that severe fatigue
was reported in almost 56% of individuals on HD (Bayumi, 2015). Jhamb et al. (2013) reported
profound levels of fatigue in 86 individuals with Stage G5 CKD. Patients after dialysis had severe
fatigue that averaged 3.4 ± 1.2 (severity scale from 1 to 5, worst) in a study conducted on 85
patients on HD (Sklar, Riesenberg, Silber, Ahmed, & Ali, 1996). In terms of ‘distress,’ fatigue has
been described as the most bothersome symptom by individuals on HD (Almutary et al., 2013;
Macdonald, Fearn, Jibani, & Marcora, 2012).
Other than the physical, cognitive, and affective components, fatigue is reported to be
severe, distressing and associated with reduced physical performance. A reduction in physical
performance happens due to muscle fatigue. Various mechanisms such as oxidative stress
(Modaresi, Nafar, & Sahraei, 2015; Scholze, Jankowski, Pedraza-Chaverri, & Evenepoel, 2016),
mitochondrial dysfunction (Che, Yuan, Huang, & Zhang, 2014), or vascular changes in the
capillaries that affect skeletal muscle function lead to fatigue (Adams, 2005). In 10 individuals on
HD, peak oxygen consumption was reduced as measured by the cycle ergometer test indicating
impaired exercise performance (Petersen et al., 2012). Another investigator reported low 6-minute
walking distance across all age groups in 90 individuals on HD (Pajek et al., 2016). From these
studies one can infer that in participants with HD, physical performance is reduced due to muscular
fatigue and, perhaps, can be demonstrated through performance- based testing.
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The literature available on epidemiology and factors associated with fatigue in CKD is
surprisingly limited by a select population with focus on African-Americans, small sample size,
inconsistencies in the correlates of fatigue, and flawed self-report fatigue measures (McCann &
Boore, 2000; Williams, Crane, & Kring, 2007). These studies have been mostly conducted outside
the US (Bossola, Luciani, & Tazza, 2009; Bossola et al., 2018, 2011, Bossola & Tazza, 2015,
2016; Letchmi et al., 2011; McCann & Boore, 2000). Fatigue is associated with negative outcomes
such as increased cardiovascular risk, morbidity and premature death (Jhamb et al., 2009; Jhamb,
Weisbord, Steel, & Unruh, 2008; Koyama et al., 2010; Sakkas & Karatzaferi, 2012). Fatigue hasn’t
been receiving much attention until recently, as it is considered an inherent part of the disease
process and something that cannot be changed or is tenable to intervention (McCann & Boore,
2000). Under-recognition of fatigue could be also due to the invisible, insidious nature of fatigue
(Horigan, 2012). In individuals on HD, fatigue remains an undertreated and under-recognized
symptom despite the high prevalence and associated critical outcomes (Artom et al., 2014;
McCann & Boore, 2000). There is a need to focus on more evidence about this negative symptom.
Fatigue Assessment in Individuals with HD
Various tools that have been used to assess fatigue in individuals with HD include
unidimensional and multidimensional tools. Some of the unidimensional tools that have been
repeatedly utilized are VAS-fatigue, the Fatigue Severity Scale, and the Short Form-36 (SF-36)
vitality scale (Artom et al., 2014; Horigan, 2012). These unidimensional tools provide a single
score in the end that measure one single aspect of fatigue such as severity or vitality. Surprisingly,
most of the studies focusing on fatigue in CKD have used unidimensional tools for assessment
(Bonner, Wellard, & Caltabiano, 2010; Bossola, Luciani, Giungi, & Tazza, 2010; Bossola &
Tazza, 2015; Jhamb et al., 2009; Karadag, Kilic, & Metin, 2013; Williams et al., 2007). The SF-
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36 vitality scale is a quality of life assessment tool that has been utilized in individuals on dialysis
to assess their fatigue levels. For example, the large scale study ‘Impact of Outcomes on
Hemodialysis (HEMO)’ study that was conducted in the US population used SF-36 to assess
fatigue (Jhamb et al., 2009, 2011). However, SF-36 scale may not completely capture fatigue
severity in the dialysis population (Jhamb et al., 2009). Also, SF-36 suffers from limitations such
as the floor effect. Another frequently used measure of fatigue, VAS, is a single item measure that
also suffers from floor and ceiling effects (Hawker, Mian, Kendzerska, & French, 2011). Floor
effect happens when most of the reported scores lie on the lower level score of the instrument,
whereas ceiling effect happens when most of the scores reported bunch together on the upper level
score of the instrument. A psychometrically sound unidimensional tool will have a normal
distribution of scores.
Among the list of multidimensional tools for fatigue assessment in individuals with HD,
the Multidimensional Fatigue Inventory-20, the Functional Assessment of Chronic Illness
Therapy-Fatigue, & the Piper Fatigue Scale (PFS) are some of the most commonly used in previous
studies (Artom et al., 2014; Horigan, 2012). Multidimensional tools give separate scores for
various subscales, and therefore, cover various aspects of fatigue in one tool such as physical,
mental, general, or affective fatigue (Whitehead, 2009). Fatigue being a multidimensional
construct

requires

multidimensional

tools.

However,

few

investigators

have

used

multidimensional tools for fatigue assessment in individuals on HD (Biniaz et al., 2013; Karakan,
Sezer, & Ozdemir, 2011; Letchmi et al., 2011; Liu, 2006; McCann & Boore, 2000). Therefore,
more studies are required that use multidimensional tools for fatigue assessment in the same
population.
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Various tools used in individuals on dialysis, either unidimensional or multidimensional
have another limitation, in that individuals have to answer questions based on their experiences in
the past weeks to months. There is a possibility for participants to suffer from recall bias. Further,
individuals on dialysis suffer from day to day and within the day (day of dialysis) variations in
fatigue that an instrument with long recall periods cannot capture (Abdel-Kader et al., 2014).
Therefore, fatigue in CKD requires tools that assess self-reported fatigue momentarily.
Performance-based tests may be a means of assessing fatigue in real time. A six- minute
walk test gives a real time assessment of the individuals’ momentary fatigue levels by measuring
the distance walked by the individual. Some investigators have reported the use of six- minute
walk test to measure physical performance in individuals on dialysis (Dziubek et al., 2016;
Manfredini et al., 2017; Pajek et al., 2016). More studies are needed utilizing objective measures
along with “gold standard” self-report measures to measure fatigue in dialysis.
Factors Influencing Fatigue in HD
There is limited research on fatigue and its associated factors in HD in the US population.
Past studies have been conducted in Taiwan, Iran, Malaysia, Turkey, Ireland, India, Australia and
Italy (Horigan, 2012). Every culture and geographical region is different, and therefore, the
severity, quality and duration of fatigue and associated factors might be different in the US
population from the other geographical regions. Myriad factors influence fatigue in individuals on
HD including physiological, psychological, and situational.
Multiple physiological factors are known that cause fatigue in individuals on chronic HD
treatment. One of the most common reasons for fatigue is sudden fluid shifts that happen during
dialysis, causing ‘post-dialysis fatigue.’ Ultrafiltration, diffusion and osmosis are some of the
processes that determine fluid shifts across the membrane (Horigan, 2012; Sklar et al., 1996). If
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too much fluid is removed during dialysis or too much weight is gained after last dialysis treatment,
fatigue can result. Another factor causing fatigue is anemia, which occurs due to insufficient
production of erythropoietin by the kidneys in Stage G5 CKD (Zadrazil & Horak, 2015). Various
other physiological factors that have been implicated in the pathogenesis of fatigue are uremia,
protein energy malnutrition, levo-carnitine deficiency, chronic inflammation, dialysis inadequacy,
presence of comorbidities such as hypertension, diabetes, cardiovascular disease, old age and sleep
disorders (Jhamb et al., 2013; Joshwa & Campbell, 2017; Joshwa, Khakha, & Mahajan, 2012).
However, equivocal relationships have been found between various physiological factors such as
anemia and uremia with fatigue. More studies are required to explore the relationship of these
variables with fatigue.
Some of the psychological factors that predict fatigue in individuals on HD and have been
studied widely are depression and anxiety. Depression is thought to cause fatigue through
inflammatory cytokines such as interleukin-6 in individuals on HD (Bossola, Di Stasio, Giungi,
Rosa, & Tazza, 2015). A moderate relationship has been found in multiple investigations between
depression and fatigue, with few investigators not finding any relationship between the two
variables (Artom et al., 2014). Other psychological factors that are associated with fatigue are
anxiety, suicide risk, stress and social support (Karadag et al., 2013; Letchmi et al., 2011).
Situational factors that are related to fatigue in individuals on HD include age, gender, race,
educational status, and marital status. Among these factors, females (Liu, 2006), white race (Artom
et al., 2014; Jhamb et al., 2009), unemployment status (Liu, 2006), and unmarried status have been
found to be associated with increased fatigue in HD. Consistently, race has been associated with
fatigue severity, but relationship with age, gender, marital status (Bayumi, 2015; McCann &
Boore, 2000; O’Sullivan & McCarthy, 2007), educational status have been equivocal across
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studies. More evidence is required to explore these relationships. Variability in the findings limits
our ability to propose interventions for those who are at high risk of developing fatigue (Picariello,
Moss-Morris, Macdougall, & Chilcot, 2017).
Given that the existing evidence on fatigue in individuals on dialysis have been limited by
flawed unidimensional tools, lack of objective measures for fatigue assessment, underpowered
samples, variable findings in terms of the correlates of fatigue; this study aims to examine the
severity and trajectory pattern of fatigue and delineate various physiological and situational factors
that influence fatigue severity in individuals with CKD Stage G5 on HD in a powered, ethnically
diverse sample using multidimensional patient reports and performance measures. Studying the
severity and trajectory patterns of fatigue will help in identifying the dynamics of fatigue that these
individuals on HD go through. Knowledge of factors that predict fatigue may lead to identifying
individuals on dialysis that are at high risk for fatigue. Potential findings from this study may lead
to appropriate interventions to alleviate fatigue levels in participants on HD.
Significance of the Study
Number of demises occurring in Stage G5 CKD on dialysis therapy is very high, with
cardiovascular deaths contributing to more than half of the deaths (“Kidney Disease Statistics for
the United States,” 2016). Fatigue has been linked with an increased risk of cardiovascular events,
because there is a greater degree of underlying inflammation compared to healthy adults, which
contributes to coronary artery disease and mortality (Aukrust et al., 2008). Premature death is
known to occur in individuals with CKD having excessive fatigue and lower vitality scores (Jhamb
et al., 2009). Besides these significant outcomes, fatigue also may have a negative effect on an
individual’s daily performance, activities, professional life, relationship with family and friends,
sex life and course of treatment (Bonner et al., 2010). An individual with fatigue becomes
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physically inactive and becomes more dependent (Jhamb et al., 2011). The capacity to engage in
daily activity and exercise is reduced (Bonner et al., 2010). There is a considerable reduction in
mental, physical, social and functional capacities further affecting quality of life (Jhamb et al.,
2008).
Given that fatigue is associated with various negative health outcomes, such as increased
cardiovascular morbidity, mortality, increased dependence on others and reduced physical activity,
depression, and anxiety; there is a need to focus our research efforts onto this understudied
symptom. There is limited research conducted on fatigue in individuals with Stage G5 CKD on
HD in US.
This study aimed to examine the various dimensions of fatigue in the Michigan HD
population and examine the various situational and physiological factors that are related to fatigue,
and therefore would help in understanding the biological mechanisms that cause fatigue in
individuals with Stage G5 CKD on HD. This aim is in alignment with one of the research priorities
of the National Institute of Nursing Research (NINR) which proposes to understand the biologic
basis behind symptoms like fatigue in various chronic illnesses. NINR proposed that a “better
understanding of symptoms….will improve clinical management of illness and lead to more
productive lives” (“Symptom Science | National Institute of Nursing Research,” n.d.). Existing
literature on various factors associated with fatigue suggests equivocal results and therefore, this
study aimed to confirm or refute the findings from previous studies through a rigorous,
multidimensional assessment with a powered sample. Variability in the findings on factors
associated with fatigue limits our ability to propose interventions for individuals with Stage G5
CKD on HD. A predictive model of fatigue may be proposed from the results of this study data
that will accurately identify individuals at risk for severe fatigue. Currently, there is no consistent
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model to predict fatigue and management of fatigue relies primarily on treating anemia and
increasing physical activity to alleviate fatigue (Picariello et al., 2017). Appropriate interventions
directed towards high risk individuals with fatigue may help in improving quality of life and
reducing morbid cardiovascular events in the CKD population.
This study is in alignment with the mission of the American Nurses Association (“About
ANA |American Nurses Association,” n.d.), in that it will contribute to improving the health of
patients by achieving a greater quality of life in individuals with Stage G5 CKD on HD. This study
utilized the Theory of Unpleasant Symptoms (TOUS) as the framework to generate various
hypotheses based on the relevant past literature, and thereby, the results obtained from this study
provided confirming evidence towards hypothesized relationships in the theory and eventually
contributed towards the discipline of nursing.
Purpose of the Study
The purpose of this descriptive, correlational study was to examine the severity and
trajectory pattern of fatigue and delineate various physiological and situational factors that
influence fatigue severity in individuals with CKD Stage G5 on HD.
Specific Aims
Aim 1: Examine the severity and trajectory pattern of fatigue in individuals with Stage G5
CKD on HD.
Research Question 1a: How severe was the level of behavioral, cognitive and affective fatigue pre
and post dialysis?
Research Question 1b: How frequently did the HD participants describe being fatigued?
Research Question 1c: Did the mean fatigue scores differ from U.S. and other chronic disease
populations?
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Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to the postdialysis period?
Research Question 1e: What was the impact of fatigue on the physical performance of HD
participants pre and post dialysis?
Aim 2: Identify the extent to which select physiological factors such as anemia, dialysis
adequacy, inter-dialytic weight gain, co-morbidities, and age influence fatigue severity in
individuals with Stage G5 CKD on HD.
Hypothesis 2: There was no relationship between anemia, dialysis adequacy, co-morbidities, interdialytic weight gain and age with fatigue severity.
Aim 3: Identify the extent to which select situational factors such as living status,
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD
on HD.
Hypothesis 3: There was no significant difference in fatigue severity with respect to gender, race,
employment, and living status.
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CHAPTER 2: THEORETICAL FRAMEWORK AND SELECTION OF VARIABLES
Theory of Unpleasant Symptoms (TOUS)
The TOUS was used to guide the present study. According to Lenz & Pugh (2018), the
TOUS was designed to improve understanding of a symptom in various contexts and provide
information on designing new ways to prevent, ameliorate or manage unpleasant symptoms and
their negative effects. The theory has three major concepts- the symptoms, influencing factors, and
performance outcomes. The theory states that three interrelated categories of factors particularly,
physiological, psychological, and situational factors influence a given symptom, the experience of
that symptom and how an individual perceives a symptom. The ‘symptom experience’ affects the
individual’s performance, which encompasses cognitive, physical, and social functioning (see
Figure 1) (Lenz & Pugh, 2018).
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Figure 1. Theory of unpleasant symptoms (Lenz and Pugh, 2018)
Symptoms can be isolated or are clustered and are reported by the individual; sometimes
objective signs are apparent. Symptoms are affected by various contextual factors (Lenz & Pugh,
2018). The rationale behind selecting this middle-range theory is that it focuses on
symptom/symptoms, highlights multidimensionality, and delineates various factors that influence
a given symptom, which was in alignment with the purpose of this proposed study. Symptoms are
subjective and can be measured only through self-report although objective signs may be visible.
Therefore, this study focused on a combination of subjective reports and objective performance
measures to study fatigue. Also, the TOUS suggests that symptom is an unpleasant concept, and
since fatigue is an unpleasant and distressing symptom, the TOUS seemed to be a perfect fit for
this proposed study.
Propositions of Interest
The propositions from TOUS that are linking the concepts of interest are the following: (1) A
symptom has multiple measurable dimensions including quality, distress, severity and timing as it
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occurs. (2) Physiological factors, situational factors, and psychological factors influence a
symptom and its dimensions.
Theoretical Constructs
The two major constructs that are of interest from TOUS for this study are symptoms and
influencing factors.
Symptoms. According to Lenz & Pugh (2018), symptoms are defined as perceived
indicators of change in normal functioning as experienced by individuals. Symptoms are
conceptualized as having measurable dimensions such as quality, intensity/severity, distress and
time as shown in Figure 1. ‘Quality’ is the nature of the symptom or the way it is manifested or
experienced. ‘Intensity’ refers to the degree, strength, or severity of the symptom. ‘Distress’ is the
degree to which the individual experiencing the symptom is bothered by it. The dimension of ‘time’
defines the frequency and duration of the symptom (Lenz & Pugh, 2018). The present study
focused on fatigue as a symptom and measured various dimensions including intensity/severity
and timing of fatigue experienced by the person. Severity of fatigue was the dependent variable in
this study. The present study examined the level of sensory, cognitive and affective fatigue and
has been added in Figure 2.
The TOUS states that symptoms can have observable signs along with subjective feelings
(Lenz & Pugh, 2018). Therefore, this study utilized an objective measure to assess fatigue
indirectly through reduced physical performance.
Influencing factors. Influencing factors are the factors that are relevant in producing a
given symptom which includes physiological, situational and psychological factors.
Physiological factors. These factors include anatomical, physiological, genetic and
treatment-related variables. For instance, the presence of structural anomalies, existence of
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pathology, stage or duration of illness, inflammation due to infection and age are examples.
Relevant physiological factors that were measured in this study follow.
Anemia. Anemia is caused due to reduced production of erythropoietin by the kidneys in
CKD, and fatigue is a manifestation of anemia especially in HD. Anemia in CKD is diagnosed by
serum hemoglobin values falling below 13 grams per deciliter (g/dL) in males and below 12 g/dL
in females(“Anemia in CKD | KDIGO,” 2012). Various investigators have looked at the
relationship between anemia and fatigue. In a longitudinal study conducted on 28 individuals in
Australia suffering from Stages 3-5 CKD, low serum hemoglobin was moderately correlated with
fatigue (r = .39, p < .05) (Bonner et al., 2013), with similar findings reported by a few investigators
(Jhamb et al., 2013; Karakan et al., 2011; Williams et al., 2007). Contradictory findings have been
reported by a majority of the investigators, in that they did not report a significant association
between anemia and fatigue in individuals with CKD on HD (Bossola, Di Stasio, Antocicco, &
Tazza, 2013; Bossola et al., 2009; Jhamb et al., 2009; Letchmi et al., 2011; Liu, 2006; McCann &
Boore, 2000). These equivocal findings may be due to erythropoietin therapy and having
homogenous levels of hemoglobin. Further exploration into the relationship between anemia and
fatigue severity was done.
Co-morbidities. Co-morbidities refers to the disorders that an individual is suffering from
at a time. A study conducted in individuals on hemodialysis reported that individuals with worse
fatigue were more likely to have severe comorbidities (Jhamb et al., 2009). Another study reported
a similar finding, with significantly positive correlations between post-dialysis fatigue and
comorbidities (r = .14, p = .031) (Han & Kim, 2015). The present study explored relationship
between pre-dialysis fatigue and post-dialysis fatigue with comorbidity scores.
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Inter-dialytic weight gain (IDWG). IDWG is the difference in the weight between two
consecutive dialysis sessions due to fluid and salt accumulation. The weight gained is calculated
from pre-dialysis weight minus the post-dialysis weight of the previous HD session. Normally, a
70 kg individual should gain 2.4 kg between dialysis sessions (Daugirdas et al., 2015). A weak
correlation of fatigue with IDWG (r = .25, p < .05) was reported in a group of 104 individuals on
HD in Korea (Kim & Son, 2005). Higher IDWG are associated with higher fluid removals during
a HD session and thereby higher ultrafiltration rate which might be contributing to greater fatigue
levels. Exploration about the relationship between IDWG and fatigue severity was done.
Age. A weak, positive insignificant correlation was found between fatigue and age in an Irish
study in 46 individuals on HD (r = .20, p = .09) (O’Sullivan & McCarthy, 2007). Older participants
with CKD have significantly higher levels of fatigue than younger participants (Liu, 2006).
Consistent findings have been reported on older participants tending to be more fatigued in
participants on HD (Bossola et al., 2009; Kim & Son, 2005; Letchmi et al., 2011). One possible
explanation is that older participants have more co-morbidities compared to younger participants,
contributing to higher fatigue levels. Further exploration of age and fatigue severity was done in
this study.
Dialysis adequacy. Dialysis adequacy is measured by various methods and calculation of Kt/V
is one of them (“Hemodialysis Dose & Adequacy | NIDDK,” 2014). A value of 1.2 or higher
indicates adequate dialysis. Many investigators have not found an association between fatigue and
inadequate dialysis (Bossola et al., 2018; Liu, 2006; Mollaoglu, 2009). An investigator in Iran
found significant association (p = .01) between fatigue and dialysis adequacy in 43 patients on HD
(Dadgari, Dadvar, & Eslam-Panah, 2015). Inadequate dialysis causes a higher circulation of
uremic solutes in the blood and may cause fatigue in patients on HD. Investigators have found
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association between uremia and fatigue levels in the past (Wang et al., 2016). Uremia might be
acting as a mediator of the relationship between dialysis inadequacy and fatigue. Further
exploration of relationship between dialysis adequacy and fatigue was done in this study.
Situational factors. According to TOUS, situational factors encompasses individual’s
social and physical environment. Examples are socio economic status, living status, temperature,
light, pollution, and others (Lenz & Pugh, 2018). The situational factors in the present study
included living status, employment status, race and gender; a review of which is provided below.
Living status. Living status means if the individual resides with anyone such as spouse,
parents, relatives, or no-one. No significant difference between fatigue and being married versus
not married (F (3, 41) = .50, p = .68) was found (O’Sullivan & McCarthy, 2007). Similar findings
were reported by McCann & Boore (2000) and Bayumi (2015). The reason behind married
individuals having lower fatigue levels could be due to the moral and psychological support
provided by the spouse (Liu, 2006), however, none of the previous studies have found any
relationship between marital status and fatigue. By convention, marital status has been studied
frequently. The present study explored the relationship between fatigue severity and living status
as living status may be a more relevant construct than marital status.
Employment. Unemployed individuals were more fatigued than their employed
counterparts in Taiwan individuals on HD (Lee et al., 2007). Usually staying at home when
unemployed might decrease physical activity and social support from colleagues, thereby
increasing fatigue levels. Contrasting findings were reported by other investigators (McCann &
Boore, 2000; O’Sullivan & McCarthy, 2007). The present study explored more about relationship
between employment status and fatigue severity.
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Gender. The majority of investigators have reported females being more fatigued than
males, which could be due to females articulating their feelings more than males (O’Sullivan &
McCarthy, 2007). Females were more fatigued than males in Taiwanese individuals on HD (Liu,
2006). Similar findings have been reported by other investigators (Kim & Son, 2005).
Contradictory findings were reported by Bayumi (2015), in that men were more fatigued compared
to women in participants receiving HD therapy. No significant difference in fatigue scores was
observed between males and females in an Irish study on 39 individuals on HD (McCann & Boore,
2000). Further exploration was done on the relationship between gender and fatigue severity in
this study.
Race. Among 36 African-American females on HD, 75% were reported to be fatigued
(Williams et al., 2007). However, another investigator reported fatigue to be less prevalent in
African-Americans and Asians compared to non-African-Americans (Artom et al., 2014).
Similarly, African-American individuals on dialysis reported more energy than non-AfricanAmericans (Jhamb et al., 2009). Caucasians take longer to recover from fatigue after dialysis
sessions than African-Americans (Cardenas & Kutner, 1982). In fact, African Americans reported
better psychological well-being and lower burden of disease in another study (Unruh et al., 2004).
With CKD being more prevalent in African-Americans (“Kidney Disease Statistics for the United
States,” 2016), one would postulate that fatigue will be more prevalent in African-Americans. The
paradoxical findings might be due to greater spiritual well-being in African-Americans (Tanyi &
Werner, 2007). The present study explored relationship between fatigue severity and race.
Amongst the influencing factors proposed for this study, consistent relationships have been
observed between race, age and fatigue severity. Other influencing factors in CKD that have shown
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equivocal relationships with fatigue include anemia, living status, gender, and employment status.
Variables such as IDWG have been examined only by a few studies and was explored in this study.
Theoretical Model
The conceptual model shown in Figure 2 summarizes TOUS and hypothesized
relationships that are relevant to the present research study. The middle range theory concepts are
shown along with the variables from literature review in fatigued individuals with CKD. Figure 3
illustrates the application of TOUS to the select variables chosen for this study. In addition,
measures for the select variables are identified and are described in the next chapter.
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Figure 2. Conceptual theoretical model based on Theory of Unpleasant Symptoms

Figure 3. Substruction model showing relevant concepts, variables and empirical indicators
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CHAPTER 3: METHODOLOGY
Purpose of the Study
The purpose of this descriptive, correlational study was to examine the severity and
trajectory pattern of fatigue and delineate select physiological and situational factors that
influenced fatigue severity in individuals with CKD Stage G5 on HD.
Specific Aims and Hypothesis
Aim 1: Examine severity and trajectory pattern of fatigue in individuals with Stage G5 CKD
on HD.
Research Question 1a: How severe was the level of behavioral, cognitive and affective fatigue pre
and post dialysis?
Research Question 1b: How frequently the HD participants described being fatigued?
Research Question 1c: Did the mean fatigue scores differ from U.S. and other chronic disease
populations?
Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to the postdialysis period?
Research Question 1e: What was the impact of fatigue on the physical performance of HD
participants pre and post dialysis?
Aim 2: Identify the extent to which select physiological factors such as anemia, dialysis
adequacy, inter-dialytic weight gain, comorbidities, and age influence fatigue severity in
individuals with Stage G5 CKD on HD.
Hypothesis 2: There was no relationship between anemia, inter-dialytic weight gain, dialysis
adequacy, co-morbidities, and age with fatigue severity.
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Aim 3: Identify the extent to which select situational factors such as living status,
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD
on HD.
Hypothesis 3: There was no significant difference in fatigue severity with respect to gender, and
employment, race and living status.
Design
A quantitative, non-experimental, descriptive, correlational, before-after design was
utilized in this study. A before-after design was considered because of the significant diurnal
changes in fatigue severity levels and some of the associated factors, before and after dialysis. A
pictorial representation of the research design is shown in Figure 4. The primary outcome measures
were fatigue severity, whereas, the independent variables were anemia, IDWG, dialysis adequacy,
age, comorbidities, living status, gender, employment status, and race.

Figure 4. Non-experimental, before-after design
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Sample
A non-probability, convenience sampling method was employed, since the study included
only those patients who were visiting collaborating clinics, a description of which is provided in
section ‘Setting.’ Individuals were screened according to the following inclusion/exclusion
criteria.
Inclusion/ Exclusion Criteria
The inclusion criteria involved the following: (1) Participants who provided consent to
participate and were between 18-89 years. (2) Participants who could understand/ converse in
English language. (3) Participants with established diagnosis of CKD Stage G5 greater than 3
months and were on HD twice or thrice per week. (4) Participants who were conscious and alert
enough to answer the questions according to Mini Cognitive assessment score (Appendix-A).
The exclusion criteria for 6-minute walk test included: (1) Participants who had mobility
restrictions and relied on wheelchair for transportation purposes. (2) Participants who were unable
to walk. (3) Participants who did not give a verbal approval or were not confident to walk. (4)
Visual gait checks on the patient prior to walk showed instability to walk. (5) Participants with
conditions such as unstable angina during the previous month, recent myocardial infarction in the
previous month, resting heart rate of more than 120 per minute, & hypotension (Blood pressure<
90/50 mmHg) at time of 6MWT. (6) Patient reported about hypotensive signs like light
headedness, nausea, vomiting and cramps. (7) Any episodes of intradialytic hypertension
associated with an increase in systolic blood pressure >90 mmHg from pre-dialysis to post dialysis.
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Setting
The target population was individuals diagnosed with CKD Stage G5 and were on HD
twice or thrice a week. Our accessible population were individuals who were visiting the selective
outpatient DaVita dialysis clinics in South East Michigan. Individuals who visited these dialysis
clinics were primarily from Metro Detroit and Southeast Michigan. DaVita Health Care is a nonprofit organization that has a chain of approximately 1500 dialysis clinics across the United States.
The initial point of contact was the feasibility coordinator, who handled activities at the DaVita
Clinical Research Center. This research center has a Protocol Review Committee that monitors
research activities at DaVita across the U.S. After the Protocol Review Committee approved the
study protocol, the PI reached out to the 3 DaVita dialysis clinics that participated in the study.
Selection of these 3 clinics was based on feasibility and ethnic mix of population and a summary
of the clinics is provided in Table 2. Permissions were obtained from the specific Regional
Operational Director, Facility Administrator and Medical Directors of these clinics through emails
and in-person meetings before beginning the project.
Table 2
Summary of Participating Sites
Facility

Location

DaVita Health Care
DaVita Health Care
DaVita Health Care

Clinton Township
Macomb
Partridge Creek

Distance from WSU*
campus(miles)
26
14.5
28.1

Dialysis patients
enrolled in clinic
60
90
40

*WSU: Wayne State University

Sample Size
The actual power depends on the specific statistical test used for a given sample size and
estimated effect size. The apriori power analyses were run and findings are as follows. For research
questions 1d & 1e, using paired samples test, a sample of 34 participants was required. This sample
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size is based on a formulation of 80% power, a medium effect size of 0.5, and a significance of
0.05. For Hypothesis 2, using Pearson Correlation, 64 participants were required. This sample size
is based on a formulation of 80% power, a medium effect size of 0.3, and a significance of 0.05.
For Hypothesis 3, using Chi-square test, a sample of 110 participants was required. This sample
size is based on a formulation of 80% power, a medium effect size of 0.3, and a significance of
0.05. To address all the hypotheses in this study, approximately 110 participants were required.
Sample size calculations were performed using the G power 3 (Faul, Erdfelder, Buchner, & Lang,
2009). Based on the declination rates, we expected a 40% attrition rate and the total targeted sample
size was increased to 150 participants.
Post-hoc power analyses were done to see if there was enough power in the study. For Chisquare, this study achieved 89% power with a moderate effect size with 86 participants. For
multiple regression, with five predictors there was 77% power. For logistic regression, a power of
42% was achieved with an odds ratio of 1.5. For running t-tests, there was a power of 99% with
moderate effect size. For independent t-tests, there was 95% power based on 86 participants in the
study.
Recruitment Procedures and Screening
Permission from the Institutional Review Board of Wayne State University (Appendix-C)
was obtained for ethical clearance in February 2018. A letter of support (Appendix-C) was
obtained from DaVita Clinic Research Center and after the Protocol Review Committee approved
the study in April 2018, the project began at the specific dialysis clinics in May 2018. The principal
investigator (PI) reached out to the specific dialysis clinic Facility Administrators/Medical
Directors and explained what was needed from the clinic staff. Data were collected from May 2018
to December 2018.
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The staff were involved in screening the participants and completed Health Insurance
Portability and Accountability Act of 1996 (HIPAA) form (Appendix-B) with the participants who
were interested in the study. A waiver from IRB was requested to screen participants for eligibility
before taking informed consent. Based on the inclusion criteria, participants were screened
(Appendix-A) to look for eligibility by the dialysis clinic staff. If the patient was eligible, the
dialysis clinic staff completed HIPAA form with the participants. The PI obtained informed
consent (Appendix-B) from the participants who completed HIPAA from those who were
interested in participating in Visit 1. A detailed description of the study was provided to the
participant during the consent process. A mutually agreeable day of future dialysis was decided
for interviewing the patient. Participants received 10-dollar gift cards after Visit 1 as a token of
appreciation. Gift cards were from Walmart/Target/Meijer store.
On the day of interview (Visit 2), before dialysis was initiated, interview was conducted
for 15 minutes to measure fatigue levels using self-report measures, demographic information
(age, living status, employment status, gender and race) and information about comorbidities
(Appendix-A). After the interview, participants were screened for the 6MWT (Appendix-A). Vital
signs (Heart Rate, Blood Pressure) were measured by the PI. If the participant was eligible for
6MWT based on vital signs and walking history, the 6MWT was conducted. The 6MWT session
took 15 minutes. Participants ineligible for 6MWT returned to the dialysis clinic for their dialysis
session. Participants received 20-dollar gift cards after completing the pre-dialysis session.
On the same day of interview (Visit 2) after the dialysis session, there was a post-dialysis
interview session. The post dialysis interview session included measurement of fatigue levels using
self-report measures. Vital signs were measured by the PI to determine eligibility for the 6MWT.
The 6MWT was repeated after the post-dialysis interview based on the same screening criteria
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used pre-dialysis. Participants received 20-dollar gift cards after completing the post-dialysis
session.
Weight was measured pre and post dialysis using the weighing scale installed in the
specific dialysis clinics. Other necessary data (serum hemoglobin, recent dialysis adequacy and
IDWG) were extracted from the medical records of the patient.
Various strategies were employed to advertise about the research study and encourage
participation. DaVita specific flyers (Appendix-B) were distributed to the staff/nurses of specific
dialysis clinics. Nurses and dialysis staff helped in spreading information about the study through
word of mouth.
A few amendments were made in the study protocol and approved by the IRB in June,
August 2018, and February 2019 regarding change in exclusion criteria, increase of enrollment
number, deletion of key personnel, addition of key personnel and funding source. A continuation
form was submitted to IRB in January 2019 to continue the study in case medical records need to
be referred in the post enrollment and analyses period. The continuation was accepted by IRB in
February 2019.
Instruments
This study included the following outcome measures derived from the TOUS.
Fatigue and Multiple Dimensions
This study measured quality, severity and timing of fatigue. The Piper Fatigue Scale-12
(PFS-12) (Appendix-A) was used to measure fatigue severity and quality. The Patient Reported
Outcomes Measurement Information System-Computer Adaptive Test (PROMIS CAT) for
Fatigue (Appendix-A) measured fatigue severity and timing of fatigue. The 6-minute walk test
(6MWT) (Appendix-A) was used to measure quality of fatigue, specifically motor fatigue.
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Piper fatigue scale. A description of Piper Fatigue Scale follows.
History. The Piper Fatigue Scale (PFS) was originally developed by Dr. Barbara Piper in
1989 to measure multidimensional aspects of fatigue in individuals suffering from cancer. PFS is
a self-reported, multidimensional measurement scale that measures subjective perception of
current levels of fatigue. The original version of PFS contained 40 items (Piper et al., 1998, 1989).
However, due to various limitations observed in PFS such as comprehension difficulty with the
response scale, lengthy questionnaire, respondent burden and being impractical for quick
assessments (Reeve et al., 2012), the shorter versions of Piper Fatigue Scale has been released.
The 12-item version, PFS-12 was used in this study.
Dimensions. The PFS-12 scale is composed of 12 numerically scaled items that measure
four dimensions of fatigue using a simple rating from 0 to10 for each item. The four subjective
dimensions are behavioral/severity, affective meaning, sensory, and cognitive/mood. The
behavioral/severity dimension (three items) reflects the severity, distress of fatigue and changes in
activities of daily living that could result from fatigue. The affective meaning dimension (three
items) focuses on emotional meaning attributed to fatigue. The sensory dimension (three items)
includes sensory symptoms of fatigue perceived physically such as feeling weak and tired. The
cognitive/mood dimension (items items) includes perceptions of cognitive ability like difficulty
with concentration/remembering ability (Clark, Ashford, Burt, Aycock, & Kimble, 2006).
Scoring. In order to calculate the subscale/dimension scores, the scores of all items within
the particular subscale are added, and this sum is then divided by the number of items within the
particular subscale. This calculation provides us with a mean subscale score for the participant
from 0 to 10. Similarly, a total fatigue score can be obtained by adding the 4 subscale scores and
dividing this sum by 4. A total score of 0 means ‘no’ fatigue, 1 to 3 means ‘mild’ fatigue, 4 to 6
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means ‘moderate’ fatigue, and 7 to 10 means ‘severe’ fatigue. These cut off scores have been
validated in a group of breast cancer survivors (Stover et al., 2013). Higher scores on the subscale
and the total fatigue scale reflect severe fatigue.
Psychometrics. Excellent internal consistency of PFS-12 has been reported in a study with
799 women survivors from breast cancer. PFS-12 had a Cronbach’s alpha of .92, along with the
reliability for the PFS-12 subscales .89 (behavioral), .87 (cognitive/mood), .87 (affective), and .87
(sensory) (Reeve et al., 2012). Another investigator found a similar Cronbach’s alpha reliability
for the PFS-12 scale of .92 in 857 women survivors from breast cancer. Weak convergent validity
was found between the PFS-12 and SF-36 physical function subscale (r = − .374, p < . 01), and
moderate validity with the SF-36 mental function subscale (r = −.59, p < . 01) (Stover et al., 2013).
A previous study that utilized PFS with 22 items in dialysis population did not report the validity
in their findings (Karakan et al., 2011).
The Cronbach’s alpha for the total scale in the current study was excellent, was .91 before
dialysis and .94 after dialysis. For behavioral subscale alpha was .86 before dialysis, .92 after
dialysis; affective subscale was .89 before dialysis, .93 after dialysis; sensory was .89 before
dialysis, .91 after dialysis.; cognitive was .82 before dialysis and .79 after dialysis.
Rationale for using PFS-12. The PFS-12 is a multidimensional tool and measured
specifically four aspects of fatigue that are reported in individuals on HD. Physical, cognitive and
affective fatigue were reported in Taiwanese individuals on HD using a phenomenological
approach (Lee et al., 2007). The behavioral/severity and sensory subscale of PFS-12 may be
related to the physical aspects of fatigue in HD and cognitive and affective subscale of PFS-12
might be related to the psychological aspects of fatigue in individuals on HD.
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Other multidimensional tools like the Multidimensional Fatigue Inventory-20 have been
accused of not having an appropriate factor structure (Chilcot et al., 2017), and difficulty in
comprehending the instrument (Artom et al., 2014). The Functional Assessment of Chronic Illness
Therapy-fatigue is another tool that does not cover various aspects of fatigue such as behavioral,
sensory, affective and cognitive domains (E. Smith, Lai, & Cella, 2010). Unidimensional tools like
VAS, Fatigue Severity Scale only measure one aspect of fatigue and therefore, not appropriate for
use in dialysis fatigue that has multiple dimensions (Whitehead, 2009). The revised and shorter
version of PFS is preferred over the original version of PFS in the present study as it has 12 items
compared to the 40 items in the original version, and therefore, there will be reduced respondent
burden. Validity and reliability of PFS-12 has been shown to be acceptable in the past few studies
(Reeve et al., 2012; Stover et al., 2013). To our knowledge, PFS-12 has not been utilized in the
dialysis population before. Other versions of PFS, that has 22 items have been utilized in dialysis
population (Karakan et al., 2011). The instrument is available free of cost and does not require any
special training to administer.
The recall period of PFS-12 is of current or 24 hours which is better than a 1 week recall
period of other tools like Functional Assessment of Chronic Illness Therapy fatigue, and
Multidimensional Fatigue Inventory-20. Greater chances of error can happen in a 1 week recall
method. The peak-end cognitive heuristic rule states that the most intense (peak) and final (end)
moments of an experience has an influence on the judgements made by a person retrospectively.
This influence can bias self-reports of somatic symptoms. Surprisingly, an investigator reported
that peak and end experiences do not have a significant effect on daily recall of fatigue in
individuals with rheumatic disorders (Schneider, Stone, Schwartz, & Broderick, 2011). In patients
with osteoarthritis related low back pain, it was found that recalled overall daily pain is highly
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concordant with the average of several momentary pain measurements carried out on the same day
(Perrot et al., 2011). Therefore, it can be postulated that a 24-hour recall is concordant with a
person’s momentary symptom experience. The present study utilized PFS-12 which is a current or
24-hour recall tool that is postulated to adequately measure the momentary, daily variations of
fatigue in the dialysis population.
PROMIS measures. The PROMIS measures were developed by National Institutes of
Health (NIH) to assess a variety of outcomes and symptoms such as pain, fatigue, physical
function, depression, anxiety and social function. PROMIS measures are standardized and
rigorously tested in various populations (“PROMIS,” n.d.).
PROMIS-fatigue. PROMIS fatigue measures mild to extreme sensations of tiredness and
its impact on various aspects of life, including physical, social and mental activities. The
instrument covers especially the experience of fatigue in terms of its intensity, duration and
frequency in the past 7 days (“Patient-Reported Outcomes Measurement Systems- Fatigue,” 2015).
This proposed study utilized PROMIS CAT fatigue for measuring fatigue pre-dialysis.
PROMIS fatigue can be administered in short form and computer adaptive testing format
to adults, children and parent proxies. Short forms are much shorter versions of this instrument,
while the CAT format provides questions to the individual based on responses given. There are a
total of 95 questions in the item bank, from which questions are retrieved.
In PROMIS CAT, the computer provides questions with medium trait level initially. The
next item is administered according to the individual’s previous response. The total time to
administer the test is 3 to 5 minutes. The scores obtained from the individual responses are summed
into a total also known as the ‘raw score,’ which is then converted to a T-score by the computer.
In order to receive a fatigue score, an individual must respond to four to 12 items. The number of
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items provided is response dependent and varies with every individual. The responses of the
questions have five options ranging from ‘not at all’ to ‘very much.’ Questions that measure
frequency have response options ranging from ‘never’ to ‘always.’ More questions administered
to the individual decreases the chances of error in the scores obtained. A total score of 50 with a
standard deviation of 10 is considered an average score. For fatigue, a score of 60 is 1 SD worse
than average, and a score of 40 is 1 SD better than average. Therefore, higher scores obtained
indicate more severe fatigue. The instrument is available free of cost from the Assessment Center
on the National Institute of Health website, however, requires registration from the user (“PatientReported Outcomes Measurement Systems- Fatigue,” 2015).
Psychometrics. Test-retest reliability was established in two studies. PROMIS CAT fatigue
was administered to 100 individuals with osteoarthritis and 100 from the general population, with
the retest administered after 7 days, in that desirable test-retest reliability coefficients were
obtained ranging from .80 to .92 (Broderick, Schneider, Junghaenel, Schwartz, & Stone, 2013).
Similarly, another study conducted on 177 individuals with rheumatoid arthritis found desirable
test-retest reliability estimates of .88 with the retest being administered after 2 days (Bartlett et al.,
2015).
Repeatedly, good to excellent internal consistency has been reported. Internal consistency
of PROMIS CAT fatigue was found to be .98 in individuals with rheumatoid arthritis (Bartlett et
al., 2015). The internal consistency of PROMIS CAT fatigue is excellent when scale score ranges
from 30 to 90 (“Patient-Reported Outcomes Measurement Systems- Fatigue,” 2015). Good
internal consistency of .83 for PROMIS fatigue short form was reported in 60 individuals with
sickle cell disease (Ameringer, Elswick Jr, & Smith, 2014). There are no studies that have utilized
PROMIS-fatigue in HD population to our knowledge. A systematic review done by Ju et al (2018)
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confirmed the same (Ju, Unruh, et al., 2018). In the current study, the Cronbach’s alpha was
excellent (α =.96) based on five items administered to the individual.
Concurrent validity of PROMIS CAT fatigue was found in correlating PROMIS CAT
fatigue with Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) (r = .76) with
no p-value reported (Khanna et al., 2012). Correlation of PROMIS CAT fatigue with VAS-fatigue
was .86 (p < .01) (Bartlett et al., 2015), with Fatigue Impact Scale was .86 in 133 individuals with
multiple sclerosis (Senders, Hanes, Bourdette, Whitham, & Shinto, 2014).
All domains of PROMIS measures including fatigue were administered to 100 individuals
with osteoarthritis and 100 from the general population, where mean scores on each domain in
osteoarthritis sample exceeded those from the general population (p < .001) thus, establishing
known group validity (Broderick et al., 2013).
Moderate discriminant validity of PROMIS CAT fatigue has been reported, in that the
correlation of fatigue with differing constructs such as sleep, anxiety and depression being
moderate to low. For example, correlation between PROMIS CAT fatigue and Center for
Epidemiological Studies-Depression (depression scale) was .59, and with the Sleep Index scale
was .49 in 143 individuals with scleroderma (Khanna et al., 2012). Similarly, moderate correlation
of PROMIS CAT fatigue was reported with other differing constructs in PROMIS subscales, in
that correlation with sleep subscale was .45, with depression subscale was .49 (Bartlett et al., 2015).
Mild correlation of PROMIS fatigue with State Trait Anxiety Scale of .47 was found (Senders et
al., 2014). All these correlations are in the moderate range from .30 to .50, suggesting that the
discriminant validity is moderate.
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Good convergence validity has been reported for PROMIS CAT fatigue, where it was
significantly correlated with PROMIS fatigue short form (r = .88, p < .001) in 100 stable and 85
individuals with chronic obstructive pulmonary disease (Irwin et al., 2015).
PROMIS measures also uses a score metric where each individual question is linked to a
presumed concept of fatigue, thereby increasing the validity of the instrument. The flexibility of
PROMIS CAT to choose more informative questions offers more precision compared to a short
form (Lai et al., 2011).
The PROMIS fatigue item bank was evaluated across various chronic conditions, in that
significant improvement in fatigue was observed at follow-up (Cella et al., 2016). Adequate
responsiveness was reported for PROMIS fatigue in 229 child parent dyads (Howell et al., 2016).
Advantage and rationale behind using PROMIS CAT fatigue. In this study PROMIS
CAT fatigue is superior to various unidimensional tools like Fatigue Severity Scale, Visual Analog
Scale-fatigue, Short Form-36 vitality subscale, Functional Assessment of Chronic Illness Therapyfatigue as they measure one single aspect of fatigue. PROMIS CAT fatigue provides the option of
studying various dimensions such as severity, duration and frequency of fatigue in one single tool.
PROMIS measures are reliable and valid instruments, however, due to its novelty have not been
used previously in the dialysis population. This study will be the first of its kind to use PROMISCAT for fatigue in the dialysis population. Tools such as the Functional Assessment of Chronic
Illness Therapy- fatigue used in large scale studies with the dialysis individuals suffer from floor
and ceiling effects (Acaster et al., 2015), whereas PROMIS measures have been demonstrated to
have fewer floor and ceiling effects (Khanna et al., 2012).
The PROMIS CAT fatigue was preferred over PROMIS fatigue short forms as CAT is
more precise than the PROMIS short form and therefore provides the option of having small
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sample size in the study. The items in PROMIS CAT fatigue are adjusted according to the
responses and therefore, is a personalized instrument for every participant. Also, the tool is
available at no cost and once administered instantly provides the final scores after calibrating with
the population norms (“Patient-Reported Outcomes Measurement Systems- Fatigue,” 2015).
Six-minute walk test (6MWT). 6MWT measured motor fatigue in this study and informed
‘quality’ dimension of fatigue according to TOUS.
Rationale for selecting 6MWT. Due to various advantages of objective measures in general
over self-report measures in terms of not having a recall bias and being more accurate (Polit &
Beck, 2012), this study utilized an objective measure of fatigue. Various objective tools are
available that measure fatigue, and one of the most direct way is through electromyography (EMG)
that involves measuring electrical activity in a single muscle through insertion of needle electrodes
into the skin. The cost of EMG equipment and the burden of using invasive electrodes in sick
patients limits the use of EMG in the dialysis population.
Various factors affect skeletal muscles in dialysis individuals, causing muscle fatigue also
known as motor fatigue, eventually that leads to reduced functional or exercise performance
(Adams & Vaziri, 2006). Therefore, indirectly fatigue is visible in the task a person performs and
can be measured through performance-based tests.
Various exercise-based tests have been related to muscle fatigue like treadmill/ bicycle
ergometer testing. However, these tests are not considered safe in individuals with low exercise
capacity. One of the golden standard method of measuring functional/exercise capacity is the
cardiopulmonary exercise testing that also requires a treadmill. Various timed walking tests are
also available such as 1-minute, 2-minute and 4-minute walk test which are shorter in duration,
however, are considered not sensitive enough to measure functional capacity in an individual. A
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longer duration walking test like a 12-minute walk test has been found to be too exhausting in
individuals with respiratory and cardiac problems (Du, Newton, Salamonson, Carrieri-Kohlman,
& Davidson, 2009; Venkatesh et al., 2011).
Measurement of functional performance is possible through a 6-minute walk test (6MWT).
This study used 6MWT in HD individuals as superior to all the available objective measures to
assess muscle fatigue. A 6MWT is considered safe and does not require much exertion like other
exercise-based tests. A 6MWT is performed at a submaximal level of exertion, which is similar to
the level of exertion at which one performs various activities of daily living (Pajek et al., 2016;
Venkatesh et al., 2011). A 6MWT is more feasible, available at no cost and requires no special
equipment such as EMG. Results obtained from a 6MWT are easy to interpret and does not require
much training as needed for EMG wave interpretation. Also, a 6MWT has been found to be
correlated with EMG manifestations of fatigue as measured by conduction velocity from vastus
medialis and vastus lateralis muscle during an isometric knee extension in participants with chronic
obstructive pulmonary disease (Boccia et al., 2015). In another study in multiple sclerosis
participants, strong correlation was observed with short-form 36 physical function subscale
(Goldman, Marrie, & Cohen, 2008). A detailed description of 6MWT follows.
According to the American Thoracic Society (2002), a 6MWT measures exercise tolerance
also known as functional capacity in various chronic disorders and was developed by Balke in
1963. This test measures the distance an individual walks over 6 minutes on a flat surface. The
participant is allowed to pace his walk and asked to walk as far as possible in 6 minutes in a marked
hallway. This test has been applied in pediatric, adult healthy populations and across various
diseases such as osteoarthritis, fibromyalgia, heart failure, chronic obstructive pulmonary disease
and stroke (“ATS Statement,” 2002).
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Method and contraindications. The test was performed in a hallway of length ranging
from 50 feet to 71 feet with cones placed at the beginning and end of the hallway. Ideally, the
course must be 30 meters in length, however, an investigator found no significant effect of length
course on the distance walked (Sciurba et al., 2003). Before the walk test was started, the
participant sat on a chair for 6-8 minutes and his/her pulse and blood pressure were measured to
see if it they were in normal limits. The participant was instructed to walk as quickly as possible,
with breaks if participant needed them. Comfortable shoes, clothes, and walking aids can be used
by the patient. Constant encouragement was provided frequently throughout the 6 minutes.
Training was required for the researcher who administered the test. A total of 15 minutes was
required to administer the test. The researcher performing the test is required to have Basic Life
Support and Advanced Life Support Certification in case of any adverse event during the test
(Enright, 2003).
Conditions such as unstable angina/recent myocardial infarction during the previous
month, hypertension (>180/100 mmHg), and tachycardia of resting heart rate greater than 120 are
considered contraindications as they are associated with a higher risk of cardiac arrhythmias during
the 6MWT. The present study did not use hypertension as an exclusion criterion for participants
as these individuals on dialysis are usually hypertensive on a daily basis and excluding them would
result in losing a major cross-section of the dialysis population. This decision was taken under the
discretion of the dialysis nephrologist, Medical Director, DaVita Clinton Township, Michigan.
The 6MWT test should be stopped in case of any chest pain, shortness of breath, leg cramps,
staggering, diaphoresis and pale appearance (“ATS Statement,” 2002).
Scoring. The distance covered in meters or feet was measured over 6-minutes, with lower
scores on the distance covered indicating worse function. The distance covered in healthy adults
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has been reported to range from 400 to 700 meters (Venkatesh et al., 2011). This study measured
6-minute walk distance in meters.
A substantial meaningful change in 6MWT walking distance score varies by chronic
condition. A minimal clinically important difference is the score that reflects changes and has been
estimated to be 34.4-54 meters. Specifically, in individuals with chronic obstructive pulmonary
disease, a substantial change has been estimated to be 54 meters (Rasekaba, Lee, Naughton,
Williams, & Holland, 2009), 50 meters in geriatrics (Perera, Mody, Woodman, & Studenski,
2006), and 34.4 meters in stroke (Tang, Eng, & Rand, 2012).
Psychometrics. Excellent test-retest reliability of 6MWT has been reported in a series of
studies involving various disorders, in that correlation coefficients ranged from .98 to .99 with a
30-minute rest in between (Skough, Broman, & Borg, 2013), .97 in cerebral palsy (Andersson,
Asztalos, & Mattsson, 2006), .99 in knee osteoarthritis adults (Ateef, Kulandaivelan, & Tahseen,
2016), and .96 to .98 in stroke (Wevers, Kwakkel, & Van De Port, 2011). Excellent interrater
reliability of 6MWT has been reported in 37 participants with spinal cord injury (r = .99)
(Scivoletto et al., 2011), .97 in 22 participants with spinal cord injury (Van Hedel, Wirz, & Dietz,
2005).
Appropriate predictive validity of 6MWT was estimated by correlating 6MWT with peak
oxygen consumption (VO2) over time, in that moderate correlations were exhibited after 263 days
(r = .71, p < .001) and after 381 days (r = 0.74, p < .001) in 113 patients with heart failure (Zugck
et al., 2000). Another study demonstrated appropriate predictive validity of individuals with heart
failure, in that a reduction in 6MWT walking distance predicted increased mortality in males and
females (Steffen & Nelson, 2012).
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Excellent concurrent validity was reported in individuals with Duchene’s muscular
dystrophy with timed function tests (McDonald et al., 2013), with 2-minute walk test, and with
12-minute walk test (r = .99) in individuals with stroke (Kosak & Smith, 2005).
Good discriminant validity of 6MWT was demonstrated by poor correlation with body
mass index (r = -.07) (Harada, Chiu, & Stewart, 1999). The content of 6MWT was evaluated by
54 raters, and 37% of them reported 6MWT as valid (Jackson et al., 2008). The validity of 6MWT
has not been previously reported in CKD Stage G5.
Rationale behind using self-report and objective measures of fatigue. Fatigue is selfreported by the individual through his subjective feelings. Being subjective, fatigue can be
indirectly measured through various tools that asks participants about his feelings. This study
utilized PFS-12 and PROMIS CAT fatigue as self-report tools to assess subjective fatigue. Other
than self-report tools, fatigue can be observed through the performance of an individual in his daily
activities. Reduced performance is observed in individuals on HD due to myriad reasons. This
study utilized 6MWT to measure functional performance as an objective proxy measure of fatigue
in individuals with HD. A combination of self-report and objective measures would provide more
insight about an individuals’ fatigue experience by contributing towards data triangulation.
Independent Variables (Appendix-A)
Anemia. Serum hemoglobin levels were recorded from the medical records of the
individual. On a routine basis, serum hemoglobin values are checked from blood drawn every two
weeks in individuals on HD. Before the person is initiated on dialysis, venipuncture is performed
by the nurse and blood is sent to the laboratory for hemoglobin measurement. Anemia is diagnosed
if the serum hemoglobin falls below 13 grams per deciliter (g/dL) in males and below 12 g/dL in
females (“Anemia in CKD | KDIGO,” 2012).
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Dialysis adequacy. Dialysis adequacy was measured by Kt/V. K is dialyzer clearance, the
rate at which blood passes through the dialyzer, t is for time and V is the volume of water a patient's
body contains. The most recent Kt/V was obtained from the medical records of the patient. Since
the blood test is done every month, we collected the blood records of the patient based on the
month of interview with us. Patients with lower Kt/V have more health complications and a greater
risk of death. A value of 1.2 and above is considered adequate dialysis (“Hemodialysis Dose &
Adequacy | NIDDK,” 2014).
Interdialytic weight gain. The amount of weight gained from the last dialysis session
measured in pounds is considered as the interdialytic weight gain. The difference between last
dialysis session weight and present pre-dialysis weight was determined from the medical records
of the patient.
Age, living status, employment status, gender and race. Information about these
variables were collected using self-administered questionnaire from the participant. The variable
age was an open-ended question. Living status was categorized to living with spouse/
siblings/parents/multiple relatives/ alone, total number of people in the family, number of adults
in the house, number of children in house, number of senior citizens in the house, living in own
house versus rented house versus apartment versus condominiums versus assisted living versus
shelter homes versus others. Employment status was categorized to working full time/part
time/contingent, number of jobs, number of days per week, number of hours per day.
Comorbidities. Comorbidities refers to two or more disorders present in the same person.
Comorbidities was measured by Charlson Comorbidity Index (CCI) (Appendix-A). CCI was
developed by Mary Charlson in 1987 to predict mortality at 1 year due to specific disorders
(Charlson, Pompei, Ales, & MacKenzie, 1987). CCI has been used in clinical research to predict

42
mortality, find confounding influence of comorbidities, and for self-report of comorbidities (De
Groot, Beckerman, Lankhorst, & Bouter, 2003; Roffman, Buchanan, & Allison, 2016). There are
17 comorbidities, with 2 subcategories for diabetes and liver disease. Each comorbidity is assigned
a weight or a score from 1 to 6. All the scores are added up to get a total CCI score. The severity
of comorbidity was categorized into three grades: mild, with CCI scores of 1–2; moderate, with
CCI scores of 3–4; and severe, with CCI scores ≥5. The higher the score, greater are the chances
of early mortality (Charlson et al., 1987). This measure is available free of cost and requires
minimal training. The CCI has proven to be a reliable and valid measure across various studies. In
individuals on dialysis, the inter-rater reliability of CCI was found to be excellent (r = .93)
(Bernardini, Callen, Fried, & Piraino, 2004). Concurrent validity of CCI was supported by high
correlation of comorbidity with other indices such as ICED (Index of Coexistent Diseases) ( r =
.58, p = .0001) (Gabriel, Crowson, & O’Fallon, 1999). Predictive validity was supported by reports
showing that survival time decreased when the CCI score rates went up using Kaplan-Meier curve
analysis in individuals with diabetic nephropathy (Huang et al., 2014).
Data Analysis
Research Question 1a: How severe was the level of behavioral, cognitive and affective
fatigue pre and post dialysis?
Descriptive statistics including measures of central tendency and standard deviation were used to
describe the severity of behavioral, cognitive and affective fatigue.
Research Question 1b: How frequently did the HD participants describe being fatigued?
Descriptive statistics were used to describe the frequency.
Research Question 1c: Did the mean fatigue score differ from U.S. and other chronic disease
populations?
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Independent t-test was used to test significant differences in fatigue scores.
Research Question 1d: What was the trajectory of fatigue severity from pre-dialysis to postdialysis period?
Dependent t-test were used to describe the trajectory of fatigue severity pre and post dialysis.
Research Question 1e: What was the impact of fatigue on physical performance of HD
participants pre and post dialysis?
Dependent t-test were used to describe the impact of fatigue on physical performance.
Hypothesis 2: There was no relationship between anemia, uremia, inter-dialytic weight gain,
comorbidities and age with fatigue severity.
Pearson’s correlation test/Spearman’s rank correlation was used to correlate physiological factors
with fatigue severity.
Hypothesis 3: There will be no significant difference in fatigue severity with respect to
gender, race, marital status and employment.
Chi square test was used to find significant difference in fatigue severity based on the select
situational factors.
Human Participants Protections
This study recruited participants from 3 dialysis clinics in Southeast Michigan.
Characteristics of the participants have been discussed in the inclusion/exclusion criteria section.
Sources of Materials
Information about the participants was collected from the medical records regarding the
diagnosis, and other general health information. Questionnaires were used to collect information
about their fatigue scores, & demographic information. The health information collected from the
dialysis center were used for research purposes only. Coded ID numbers were used on all
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questionnaires. Only the PI had access to participant identifiers. A master list with participant
identifiers was prepared to keep track of the patients completing data collection as there were
multiple encounters with the participants.
Potential Risks and Protections
There were no direct side effects associated with this study. However, there may have been
chest pain, shortness of breath, leg cramps, staggering, diaphoresis and pale appearance while a
6MWT was being performed, in the event of which the test would have been stopped and necessary
medical intervention would have been provided by the BLS certified nurses or personnel in the
clinic. The hallway where 6MWT was done had easy access to crash cart and an automated
external defibrillator in case of any serious adverse events. Measures were taken to exclude
participants who were at high risk for adverse events. In addition, the PI undertook BLS
certification.
Participation in this study may have increased a participant’s awareness of various
symptoms in CKD, which may cause anxiety. Basic education, counseling, and emotional support
to relieve anxiety were available from the PI. The risk for serious psychological distress from
participation in this research was expected to be minimal. However, referrals for psychological
support would have been made to a counselling clinic; but the payment of these services would
have been the responsibility of the participants.
A breach of confidentiality occurs if the signed consent form is not kept secure. Several
safeguards to ensure privacy of data were undertaken. Coded ID numbers were used on the
interview forms. All the instruments that were filled and completed were kept separately from the
forms that were completed. No identifiers were kept except for the consent form. All paper records
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were maintained in locked cabinet in a locked research office. In addition, published reports of
results will not include participant identifiers.
Participants were advised that they can withdraw their clinical data from the study analysis
at any time without penalty. Following completion of this study, the medical records and the
interview forms will continue to be stored.
Potential Benefits of Research
There was no direct benefit for participants in this research. However, the findings may
enable health care providers to improvise treatment for patients who present with a high risk for
fatigue. Findings will provide researchers with a better understanding of the pathophysiologic
mechanisms underlying fatigue in HD patients that may lead to development of interventions in
the future.
Data and Safety Monitoring Plan
Study Monitoring
The dissertation committee members including 3 senior level researchers and a statistician
along with the PI helped in monitoring the quality and standards of the research. A review was
performed on a quarterly basis to determine attrition rates, documentation of any adverse events
observed during fatigue assessment, and any missing data. This group kept an oversight of the
study as well as considered factors external to the study when interpreting the data, such as
scientific or therapeutic developments that may impact the safety of the participants or the ethics
of the study. Any changes made in the protocol were reviewed by the advisor and information was
sent to the IRB and the funding agency.
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Security Procedures for Collection, Transfer and Storage of Electronic Data
Electronic data included data collection instrument excel sheets, data sheets, recruitment
information. All the computers used for the purpose of storing research related data were password
protected. A password was required to log into Windows and then log into specific software. Data
was entered into the SPSS 22 software in a personal secured computer. Electronic copies of forms
were stored on a secure server with firewalls. The system used 128-bit encryption (SSL certificate)
to transfer data between the machines. This technology is the same as that used for online ecommerce applications to protect consumer information such as name, address, and credit card
details. Also, the servers are scanned for viruses to detect attempts at unauthorized entry.
Security Procedures for Collection, Transfer and Storage of Paper Data
Paper files consisted of participant consents, completed participant assessment
instruments. Double checking and spot checking was done during data entry. The data (hard copies
of questionnaires) were stored in a safe place in a locked cabinet with the PI. All the paper copies
of consent forms were kept separately from the completed study forms in the College of Nursing
building.
Identification of Adverse Effects
Serious adverse events include death or any breach of confidentiality. In case of any
adverse event that happened during the study would have been reported to the PI and the
dissertation committee members within 24 hours. Subsequently the IRB would have been notified
about the same. All the participants were provided with a telephone number to contact in case of
any concerns. The necessary details of the adverse event would have been entered into the
computer subsequently by the PI. The integrity of the study design was monitored as described
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below, irrespective of the fact that the anticipation for any serious adverse event during the study
is minimal.
Quality Assurance of the Data
A report was prepared regarding the key characteristics of the study participants,
completeness and quality of data. The Dissertation Advisor was involved in checking the integrity
of data storage, analyzing excessive number of “don’t know” responses. Project meetings took
place on a need basis. These meetings addressed concerns and gave project updates.
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CHAPTER 4: RESULTS
The purpose of this descriptive correlational study was to examine the severity and
trajectory pattern of fatigue and delineate various physiological and situational factors that may
influence fatigue severity in individuals with CKD Stage G5 on HD. Figure 5 shows the details
about the enrollment of participants. Altogether 93 participants consented, 86 people completed
the interviews pre-dialysis.
A total of 27 individuals declined to participate of which 20 were not interested. From these
20 individuals who were not interested in participating, 12 were receiving dialysis from Macomb
Kidney Center, six were from Clinton Township and two from Partridge Creek dialysis center. A
higher volume of patients (approximately 90 patients) receive dialysis at Macomb compared to
Partridge Creek (approximately 40 patients) and Clinton Township (approximately 60 patients),
and a higher number of individuals (n = 12) were not interested to participate from Macomb
compared to the other two. There were no significant differences between the participants who
participated (n = 86) and those who declined (n = 20), based on gender (χ2 = 1.94(1), p = .163).
There were no significant differences between participants who participated (n = 86) and those
dropped from the study (n = 7), based on gender (χ2 = .003, p = .959).
The results from data analyses have been separated into 2 sections, Section 1, description
of the sample and Section 2, results organized according to the specific aims, research questions
and hypothesis.
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Screened individuals from 3
dialysis clinics
(n=160)
Individuals meeting
screening criteria
(n=130)
Individuals approached for
informed consent
(n=120)
Individuals who consented
(n=93)
Individuals completed
interviews pre-dialysis
(n=86)
Individuals completed
interviews post-dialysis
(n=81)

Individuals performed 6 minute walk test pre-dialysis
(n=55)

Individuals performed 6 minute walk test post-dialysis
(n=44)
Figure 5. Enrollment of individuals: sampling process
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Description of the Sample
Table 3 illustrates the frequency and percentages of demographic characteristics of the
sample. Data were analyzed from a total of 86 participants who completed some measures in the
study. The majority of the sample (90.7%, n = 78) were either African Americans (48.8%) or
Caucasians (41.9%), with more males (n = 50) than females (n = 36). Most of the participants lived
alone or with their spouses, while the remaining lived with their children, siblings, parents, and
relatives. Most individuals owned their houses while others lived in an apartment, rented house,
condo/townhome, and assisted living. Many of the individuals were not working or were retired.
Table 4 illustrates the summary measures of demographic characteristics of the sample.
The age of the sample ranged from 24 to 89 years, with a mean of 61.71 years (SD = 13.81, Mdn
= 63.5). Majority (n = 53) of the individuals were less than 65 years of age, whereas lesser number
(n = 33) belonged to age group greater than 65 years. Based on race who were less than 65 years,
31 (36%) were African Americans, 22 (25.6%) were non-African Americans. Beyond 65 years of
age, 11 (22.8%) were African Americans and 22 (25.6%) were non-African Americans. There was
a significant difference in racial categories based on the two age groups, as evidenced by Chisquare test (χ2 = 5.15(1), p = .023). There were four people in the household on an average, with
two adults in the house. On an average, participants worked one day in a week.
In terms of the site where participants were getting dialyzed, 44 individuals were from
Clinton Township, 23 from Macomb, and 19 from Partridge Creek. Based on age groups, 25
individuals (56.8%) were less than 65 years, whereas 19 (43.2%) were greater than 65 years of age
at Clinton Township. At Macomb Kidney Center, there were 14 (60.9%) individuals lesser than
65 years compared to 9 individuals (39.1%) who were beyond 65 years of age. At Partridge Creek,
14 individuals (73.7%) were less than 65 years, whereas 5 people (26.3%) were beyond 65 years.

51
However, no significant differences were observed between these 3 sites, in terms on age groups
(χ2 = 1.60(2), p = .448). There were no significant differences noted between the three sites, in
terms of race (χ2 = 0.50(2), p = .779) and living status, (χ2 = 1.77(2), p = .411).
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Table 3
Frequency and Percentage of Demographic Characteristics (N=86)
Variables
Race
Asian
African American
Caucasian
Hispanic/Latino
Other
Gender
Male
Female
Employment
Fulltime
Part-time
Contingent
Not working
Number of jobs
None
One job
Living status
Spouse
Siblings
Parents
Multiple relatives
Alone
Children/son/daughter
Spouse and kids
Spouse and siblings
Friends
Living status
Own house
Rented house
Apartment
Condominium
Assisted living
Others
Townhome
Age
More than 65 years
Less than 65 years

Frequency

Percentage

1
42
36
2
5

1.2
48.8
41.9
2.3
5.8

50
36

58.1
41.9

5
5
2
74

5.8
5.8
2.3
86.0

74
12

86.0
14.0

21
3
4
4
25
14
8
3
4

24.4
3.5
4.7
4.7
29.1
16.3
9.3
3.5
4.7

38
10
20
9
2
6
1

44.2
11.6
23.3
10.5
2.3
7.0
1.2

33
53

38.3
61.6
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Table 4
Summary Measures of Demographic Characteristics
Variables

N

Range

Minimum Maximum

Mean

SD

Age (years)

86

65

24

89

61.71

13.85

No. of people in the family

86

16

0

16

4.27

2.99

No. of adults in the house

86

6

0

6

1.78

1.47

No. of children < 18 years in

86

6

0

6

0.44

1.01

86

2

0

2

0.56

0.76

No. of days working per week

86

7

0

7

0.56

1.58

No. of hours working per day

86

12

0

12

1.03

2.90

the house
No. of senior citizens in the
house

Note. SD=Standard Deviation, N=Number of subjects

Table 5 shows the summary measures of physiological data collected in the study. The
dialysis adequacy scores were adequate (>1.2) on average. The post-dialysis target weight of the
individuals ranged from 53.5 kilograms to 162 kilograms, with an average of 90.8 kgs (SD =
26.46). Individuals were anemic, both males and females on an average. A person with anemic
kidney disease on hemodialysis is recommended erythropoietin injection intravenously at low dose
if hemoglobin is below 10 gms/dL (“Anemia in Chronic Kidney Disease | NIDDK,” 2014). The
patients were on dialysis treatment for 3 and 1/2 hours on an average.
Among the individuals who completed 6-minute walk test, pre-dialysis and post-dialysis
systolic blood pressure was high on an average, while diastolic blood pressure was mildly elevated.
As shown in Table 6, the majority of the participants had arteriovenous fistula as their vascular
access for dialysis treatment.
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Table 5
Summary Measures of Physiological Data
Variables

n

Minimum

Maximum

Mean

SD

Dialysis adequacy (Kt/V)

85

0.98

2.03

1.48

0.21

Male

49

7.60

14.50

10.53

1.17

Female

36

7.10

13.30

10.41

1.22

Dialysis duration

86

150.00

300.00

216.62

25.68

IDWG

84

-2.30

6.10

2.15

1.50

Target weight

86

53.50

162.00

90.8

26.45

Weight

86

52.60

165.20

91.74

26.53

SBP pre-walk

55

108.00

234.00

149.22

29.30

DBP pre-walk

55

54.00

157.00

84.76

18.26

Pre-walk HR

55

50.00

112.00

76.38

12.44

Post-walk HR

52

59.00

130.00

88.06

18.21

Weight

86

52.20

162.10

89.84

25.78

SBP pre-walk

48

94.00

205.00

144.42

25.27

DBP pre-walk

48

54.00

125.00

82.48

15.94

Pre-walk HR

48

50.00

114.00

79.98

15.40

HR post walk

44

61.00

123.00

88.27

16.05

Serum hemoglobin

Pre-dialysis parameters

Post-dialysis parameters

Note. Weight in kilograms, hemoglobin in grams per deciliters, blood pressure in mm/Hg, Duration is in
minutes, SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure, HR= Heart Rate in beats per
minute, IDWG=Inter-dialytic weight gain, SD=Standard Deviation.
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Table 6
Frequency and Percentage of Physiological Data (N=86)
Variables

Categories

Vascular
access

Comorbidity

Frequency

Percentage

Arteriovenous fistula

61

70.9

Arteriovenous graft

20

23.3

Catheter-femoral/subclavian

5

5.8

Moderate

11

12.8

Severe

75

87.2

Analyses according to Specific Aims and Research Questions
Specific Aim 1: To describe the severity and trajectory pattern of fatigue severity in
individuals on HD.
Research Question 1a: How severe was the level of sensory, behavioral, cognitive and
affective fatigue before and after dialysis?
In the Piper Fatigue Scale, there are four subscales namely, behavioral, affective, sensory
and cognitive. Each individual subscale score is obtained by adding the 3 specific item scores
belonging to that subscale. Since each item has a score from 0 to 10, the total scores for the
subscales can range from 0 to 30. Severe fatigue ranges from 21 to 30 based on PFS subscale
scores. In this study, the scores from each subscale items were added up to get a total score for
each subscale. Table 7 illustrates the summary measures of the subscales in the pre-dialysis and
post-dialysis period. Moderate affective fatigue was the highest type reported in the pre-dialysis
period, while moderate affective and moderate sensory types were reported in the post-dialysis
period. Mild cognitive fatigue was reported during pre-dialysis and post-dialysis period. There
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were significant differences between various types of fatigue subscales pre and post-dialysis, a
detail of which is provided later in Table 12.
Table 7
Summary Measures of Fatigue Types Based on Piper Fatigue Scale
Variables

Pre-dialysis

Post-dialysis

N

Mean

SD

Maximum

N

Mean

SD

Maximum

Behavioral fatigue

86

13.79

8.66

30

81

13.86

9.55

30

Affective fatigue

86

15.24

9.07

30

81

14.27

9.60

30

Sensory fatigue

86

11.32

8.64

30

81

14.31

9.28

30

Cognitive fatigue

86

6.29

5.98

26

81

7.86

6.57

28

Note. The minimum score was 0 for all the subscales. SD= Standard Deviation, N= Sample

The total score from each PFS subscale ranges from 0 to 30. Based on original PFS-12
scoring, the subscale score ranges between 1 to 3 in ‘mild’ fatigue, 4-6 in ‘moderate’ fatigue and
7 to10 in ‘severe’ fatigue. When multiplied by 3 items based on number of items in each subscale,
these scores range from 3 to 9, 12 to 18, and 21 to 30, in ‘mild’, ‘moderate’ and ‘severe’ fatigue
respectively. Clearly, some of the scores are not accounted for such as 1, 2, 10, 11, 19, 20 are not
part of the range. That’s why, a new categorization was done to account for the scores that lie in
between. Please note that we have reclassified the categories of PFS from those previously
established (Reeve et al., 2012). In this study, the score obtained from individual PFS subscales
was categorized to 4 groups, namely, no fatigue with score of 0, mild fatigue with score from 1 to
10, moderate fatigue for a score of 11 to 20, and severe fatigue for a score of 21 to 30. Results
shown in Table 8 were obtained using same process. Table 8 shows the frequencies of various
types of fatigue and fatigue severity in the pre-dialysis and post-dialysis period. From the subjects
who reported affective and behavioral fatigue, majority of the people were in the ‘moderate’
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category. From those who reported sensory and cognitive fatigue, a majority were in the ‘mild’
category. A total of 81 people completed the PFS post-dialysis. Most reported only severe affective
fatigue (n = 26), mild sensory (n = 27), mild cognitive (n = 39) and mild behavioral fatigue (n =
29). Few patients reported no sensory fatigue (n = 5) & no behavioral fatigue (n = 6). Based on
proportions, a total of 90% people reported affective fatigue, 85% had sensory fatigue, 75% had
cognitive fatigue and 89% had behavioral fatigue pre-dialysis. In the post-dialysis period, 85% had
affective fatigue, 94% had sensory fatigue, 82% had cognitive fatigue and 93% had behavioral
fatigue.
Table 8
Frequency of Fatigue Types & Severity Based on Piper Fatigue Scale
Severity

Affective fatigue

Sensory fatigue

Cognitive fatigue

Behavioral fatigue

of fatigue

Frequency Percent

Frequency

Percent

Frequency

Percent

Frequency

Percent

Pre-Dialysis
None

9

10.5

13

15.1

21

24.4

10

11.6

Mild

16

18.6

34

39.5

48

55.8

22

25.6

Moderate

34

39.5

21

24.4

14

16.3

33

38.4

Severe

27

31.4

18

20.9

3

3.5

21

24.4

Total

86

100.0

86

100.0

86

100.0

86

100.0

None

12

14.8

5

6.2

15

18.5

6

7.4

Mild

22

27.2

27

33.3

39

48.1

29

35.8

Moderate

21

25.9

26

32.1

23

28.4

24

29.6

Severe

26

32.1

23

28.4

4

4.9

22

27.2

Total

81

100.0

81

100.0

81

100.0

81

100.0

Post-Dialysis

58
Research Question 1b. How frequently did the participants on HD describe being fatigued?
Table 9 presents the frequency of responses pre-dialysis based on the PROMIS question
‘In the past 7 days, how often did you have to push yourself to get things done because of your
fatigue?’ PROMIS-CAT for fatigue was administered pre-dialysis. A majority of the patients said
that they had suffered from fatigue ‘sometimes’ in the past 7 days. Nearly 70% (n = 61) patients
said that they had fatigue ‘often’ and ‘sometimes’ in the past 7 days. Only 9% participants reported
fatigue was present ‘always’ in the past 7 days.
Table 9
Frequency of Fatigue based on PROMIS Questionnaire
Responses

Frequency

Percent

Never

9

10

Rarely

8

9

Sometimes

38

44

Often

23

27

Always

8

9

Total

86

100

Research Question 1c. Did the mean fatigue score differ from U.S. and other chronic disease
populations?
A mean score of 50 with a standard deviation of 10 has been reported for most PROMIS
instruments when administered to the U.S. general population. The mean severity of fatigue based
on PROMIS was higher and significantly different from the average population of the U.S. (t =
5.96 (85), p < .001).
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A comparison of various fatigue scores in different disease populations (Broderick et al.,
2013; Cella et al., 2016) based on the PROMIS fatigue questionnaire is provided in Table 10. The
mean pre-dialysis fatigue scores in this study were significantly higher than individuals with cancer
(p < .001), and rheumatoid arthritis (p = .037). The mean fatigue score in this study was
significantly lower than in individuals with congestive heart failure (p = .004), COPD exacerbation
(p = .000), and major depressive disorder (p < .001) (Cella et al., 2016).
Based on this study findings, a moderate significant correlation was obtained between
PROMIS score and PFS total fatigue score pre-dialysis (r = .58, p = .000). A significant weak to
moderate correlation was obtained between PROMIS fatigue scores and all pre-dialysis PFS
subscales, affective (r = .45, p = .000), behavioral (r = .56, p = .000), sensory (r = .46, p = .000),
and cognitive (r = .322, p = .000). These findings inform convergent validity of PFS-12.
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Table 10
Fatigue Score Based on PROMIS in this Study & Other Populations
PROMIS

Disease

n

Mean

fatigue

Standard

t-score(d.f.)

p-value

Deviation

version
CAT

Osteoarthritis

100

56.2

7.8

-.29(85)

.765

CAT

CHF

60

58.8

10.4

-2.92(85)

.004

CAT

COPD exacerbation

46

62.9

8.3

-7.06(85)

<.001

CAT

COPD stable

79

56.1

8.6

-.19(85)

.843

CAT

Back pain

218

56.7

9.4

-.8(85)

.423

CAT

MDD

196

61.3

8.3

-5.45(85)

<.001

SF

Cancer

310

52

7.6

3.94(85)

<.001

SF

RA

521

53.8

8.8

2.12(85)

.037

CAT

Chronic dialysisa

86

55.9

9.18

5.96 (85)

<.001

Note. Information adapted from (Broderick et al., 2013; Cella et al., 2016), CAT= Computer
Administered Format, SF= Short Form, COPD= Chronic Obstructive Pulmonary Disorder, MDD= Major
Depressive Disorder, RA= Rheumatoid Arthritis, d.f.=degrees of freedom, aCurrent study.
Bold indicates p-value is significant

Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to
the post-dialysis period?
Table 11 shows the frequency of fatigue severity based on PFS before and after dialysis.
Based on original PFS-12 scoring, the total scale score ranges between 1 to 3 in ‘mild’ fatigue, 46 in ‘moderate’ fatigue and 7 to10 in ‘severe’ fatigue. When multiplied by 12 items based on
number of items in the scale, these scores range from 12 to 36, 48 to 72, and 84 to 120, in ‘mild’,
‘moderate’ and ‘severe’ fatigue respectively. Clearly, some of the total scale scores are not
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accounted for such as 1-11, 37-47, 73-83 are not part of the range. That’s why, a new categorization
was done to account for the scores that lie in between. The category cut-off points were rounded
to closest 10s’. The new category cut-off points adopted were 0 to 10 for “no fatigue”, “mild” for
score of 11 to 40, “moderate” for a score of 41 to 80, and “severe” for a score of 81 to 120. As
shown in Table 11, most individuals reported moderate fatigue pre-dialysis which was
significantly different than the number of individuals who reported none, mild, moderate or severe
fatigue, based on chi square test for difference in proportions. After dialysis, most individuals
reported moderate fatigue with no significant difference in fatigue levels.
Also, Table 11 shows the prevalence of patients who reported being fatigued versus not
fatigued. Almost 90.7% (n = 78) of the patients were fatigued pre-dialysis whereas 84.6% (n = 69)
of the patients were fatigued post-dialysis. However, please note that the number of patients
increased in the “severe fatigue” category from 10.5% to 24.1% respectively. The proportion
increase in ‘severe fatigue’ category was not significant from pre-dialysis to post-dialysis period
based on McNemar’s test (p = .289).
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Table 11
Fatigue Severity Based on Piper Fatigue Scale Pre-dialysis & Post-dialysis
Severity of fatigue

Pre-dialysis fatiguea

Post-dialysis fatigueb

Frequency

Percent

Frequency

Percent

None

8

9.3

12

14.8

Mild

27

31.4

23

28.4

Moderate

42

48.8

26

32.1

Severe

9

10.5

20

24.1

Total

86

100.0

81

100.0

Note. aχ2 = 36.7, d.f.= 3*, bχ2 = 5.37, d.f.= 3
*p-value is significant

Based on the total raw score from adding the scores from 12 items of PFS, mean scores
were obtained. As shown in Table 13, the mean scores of fatigue increased after dialysis. Despite
the mean fatigue scores being higher post-dialysis, results from dependent/ paired t-tests found no
statistical difference in total fatigue scores pre-dialysis and post-dialysis. In terms of different types
of fatigue based on PFS, no significant differences were obtained in pre-dialysis versus postdialysis behavioral fatigue (t (80) = -.19, p = .843) and pre-dialysis versus post-dialysis affective
fatigue (t (80) = -.87, p = .386). A significant increase was noted in pre-dialysis sensory fatigue
(M = 10.95, SD = 8.62) versus post-dialysis sensory fatigue (M = 14.30, SD = 9.28), based on
dependent t-tests (t (80) = -3.06, p = .003). A significant increase (t (80) = -2.60, p = .011) in
cognitive fatigue was noted pre versus post-dialysis as shown in Table 12.
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Table 12
Comparison of Mean Fatigue Scores Before & After dialysis Based on PFS
Variables

n

Mean

Standard

t-score

deviation

(d.f.)
-1.48 (80)

.144

-0.19 (80)

.843

-0.87 (80)

.386

-3.06 (80)

.003

-2.60 (80)

.011

Pre-D total fatigue

81

45.74

25.80

Post-D total fatigue

81

50.30

31.62

Pre-D behavioral fatigue

81

13.68

8.77

Post-D behavioral fatigue

81

13.86

9.55

Pre-D affective fatigue

81

15.16

9.15

Post-D affective fatigue

81

14.27

9.60

Pre-D sensory fatigue

81

10.95

8.62

Post-D sensory fatigue

81

14.30

9.28

Pre-D cognitive fatigue

81

5.95

5.84

Post-D cognitive fatigue

81

7.86

6.57

p-value

Note. d.f.=degrees of freedom, n=number of subjects, t=t-test, D=dialysis
Bold=p-values are significant at .05 level.

Research Question 1e: What was the impact of fatigue on physical performance of HD
participants pre and post-dialysis?
The three dialysis sites where walk tests happened had different course lengths due to
limited space availability. The course length was 50 feet in two of the sites, whereas 71 feet in the
third site. As seen in Table 13, based on dependent t-tests results, individuals walked significantly
further during the 6-minute walk test before dialysis compared to post-dialysis.
In terms of the patients’ vital signs, systolic blood pressure (t(47) = 1.86, p = .069) and
diastolic blood pressure (t(47) = 1.29, p = .203) did not differ before and after dialysis. No
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significant difference was observed in heart rate {t(41) = 0.41, p = .679}before walk pre-dialysis
versus post-dialysis. A significant difference between heart rate pre walk and post walk done predialysis {t(51)= -5.52, p = .000}, oxygen saturation pre-walk and post-walk post-dialysis{t(51) =
5.18, p = .000}. A significant difference was noted in oxygen saturation pre-walk and post-walk
post dialysis {t(41) = 3.96, p = .000}, heart rate pre-walk and post-walk post dialysis {t(43)= 3.55, p = .001}.
Table 13
Comparison of Mean 6MWD Before & After dialysis (n=44)
Variables

Mean

Standard

t-score (d.f.)

p-value

2.45(43)

.018*

deviation
Pre-dialysis 6MWD

290.22

90.22

Post-dialysis 6MWD

273.96

89.54

Note. 6MWD=6-minute walk distance, d.f.-degrees of freedom.
*p-value is significant at .05 level.

Adding all the 12 items in PFS gives the total raw score. Participants who got a total raw
score in PFS of 0 to 10 were recoded to a category of ‘no fatigue’ and those who got a raw score
of 11 to 120 were recoded to a category of ‘fatigue present.’ Independent sample t-test was done
to compare the mean 6MWD (6-minute walk distance) covered between these reclassified groups.
Individuals who reported ‘no fatigue’ walked further compared to individuals who reported some
level of fatigue (i.e. ‘fatigue present’). However, no significant difference was observed before or
after dialysis as shown in Table 14 and Table 15.
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Table 14
Summary Measures of 6MWT Based on PFS Pre-dialysis (n=55)
Fatigue severity

n

Mean of distance

Standard

walked (meters)

Deviation

No fatigue

4

316.04

151.96

Fatigue present

51

276.75

85.65

t-score (d.f.)

p-value

.83 (53)

.408

Note. d.f.=degrees of freedom, n=number of subjects, t=Dependent t-test

Table 15
Summary Measures of 6MWT Based on PFS Post-dialysis (n=44)
Fatigue severity

n

Mean of distance

Standard

t-score

walked (meters)

Deviation

(d.f.)

Fatigue absent

6

291.84

112.11

Fatigue present

38

271.13

86.95

.52 (42)

p-value

.605

Note. d.f.=degrees of freedom, n=number of subjects, t=Dependent t-test

A correlation was obtained between total raw score derived from PFS and 6MWD. A weak
but non-significant relationship was observed between fatigue score and distance walked predialysis (r = -.08, p = .567). A statistically significant inverse relationship was observed between
fatigue score and distance walked in 6 minutes post-dialysis (r = -.32, p = .034).
The mean pre-dialysis 6MWD covered was significantly lower {t = -23.89 (54), p < .001}
in this study (279.61±90.45 meters, n = 55) when compared to overall mean walk distance of
healthy subjects from seven different countries (571±90 meters, n = 444) (Casanova et al., 2011).
The mean pre-dialysis 6MWD covered was significantly lower {t = -3.14 (54), p = .003} in this
study (279.61±90.45 meters, n = 55) as compared to subjects with heart failure (318±106 meters,
n = 64).
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The 6MWD in pre-dialysis period did not correlate with PFS-12 total pre-dialysis (r = .07, p = .56), however, 6MWD in post-dialysis period significantly correlated, weakly with PFS12 total post-dialysis (r = -.32, p = .03).
Specific Aim 2: Identify the extent to which selected physiological factors such as anemia,
dialysis adequacy, inter-dialytic weight gain, co-morbidities and age influence fatigue
severity in individuals with Stage G5 CKD on HD.
Hemoglobin and Fatigue Severity
The correlation between hemoglobin values and fatigue severity scores was negative in the
pre-dialysis period and the p-value was statistically significant. The higher the hemoglobin, the
lower the fatigue scores (r = - .24, p = .027). There was a weak, negative, non-significant relation
between hemoglobin values and fatigue scores in the post-dialysis period (r = -.13, p = .250). A
weak, inverse significant correlation was obtained between hemoglobin and pre-dialysis sensory
fatigue (r = -.25, p = .020). A non-significant relation was observed with the other subscales of
PFS pre-dialysis and hemoglobin, i.e. behavioral fatigue (r = -.12, p = .265), affective fatigue (r =
-.20, p = .061), and cognitive fatigue (r = -.18, p = .095).
Dialysis Adequacy and Fatigue Severity
Dialysis adequacy was measured using recent Kt/V value from the medical records of the
individual. A pre and post -dialysis urea blood sample is withdrawn every month in order to
calculate the same. Since this value is assessed every month, this study used the Kt/V values from
the same month patient was interviewed with us. The correlation between dialysis adequacy and
pre-dialysis fatigue severity score was negative (r = -.21, p = .058) in the pre-dialysis period, and
was trending towards statistical significance.
Interdialytic Weight Gain and Fatigue Severity
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Table 16 summarizes summary measures of interdialytic weight gain according to fatigue
severity in the pre-dialysis period. Based on dependent t-tests, there was no statistically significant
difference between the mean interdialytic weight gains and fatigue severity. As seen in Table 17,
the means of interdialytic weight gain were not statistically different according to fatigue severity
post-dialysis.
Table 16
Interdialytic Weight Gain Based on PFS Pre-dialysis (n=85)
Fatigue severity

n

No fatigue
Fatigue present

7
78

Mean of interdialytic
weight gain (kgs)
1.95
2.16

Standard
Deviation
.64
1.55

t-score
(d.f.)
-.34
(83)

pvalue
.734

Note. One patient record was missing in the dataset, that’s why number of subjects has one patient
less compared to previous pre-dialysis data, d.f.=degrees of freedom, t=dependent t-tests

Table 17
Interdialytic Weight Gain Based on PFS Post-dialysis (n=80)
Fatigue severity

n

Mean of interdialytic
weight gain (kgs)

Standard
Deviation

t-score
(d.f.)

pvalue

No fatigue
Fatigue present

11
69

2.34
2.13

1.19
1.56

.42
(78)

.676

Note. One patient record was missing in the dataset, that’s why number of subjects has one patient
less compared to previous post-dialysis data, d.f.=degrees of freedom, t=dependent t-tests

Comorbidity and Fatigue Severity
A total from all the items on the Charlson Comorbidity Index (CCI) was computed. Pearson’s
correlation value was obtained between the CCI total and the total pre-dialysis PFS score. No
significant correlation was found between comorbidity scores and fatigue scores pre-dialysis (r =
.02, p = .791) and post-dialysis (r = .06, p = .581). The correlation between the PROMIS fatigue
score and comorbidity score was statistically significant (r = .21, p = .05), but was weak in strength.
The higher the comorbidities, the higher the fatigue score.
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Age and Fatigue Severity
There was a significant but weak inverse correlation between age and fatigue scores predialysis (r = -.26, p = .017) and post-dialysis (r = -.23, p = .034). Younger age was associated with
a higher fatigue score or vice versa. Based on independent t-tests, no significant difference in predialysis fatigue severity {t(84) = .09, p = .922} and post-dialysis fatigue severity {t(79) = .98, p =
.328} was observed between individuals who were less than 65 years and greater than 65 years of
age.
Regression of Physiological Factors on Fatigue Severity
Multiple regression was done on the total raw scores obtained from PFS during the predialysis period. The independent variables were interdialytic weight gain (IDWG), hemoglobin,
dialysis adequacy (Kt/V), age and CCI scores. Findings from multiple regression are shown in
Table 18. The multiple regression coefficient, R indicates a moderate level of prediction. Adjusted
R-square signifies the percentage of variance explained by the model. Based on adjusted R-square,
about 16.7% of variance in total scores of fatigue severity is predicted by the physiological factors.
The physiological factors significantly predicted pre-dialysis fatigue severity, F = 4.28 (5,77), p =
.002. Among these physiological factors, hemoglobin, dialysis adequacy, and age significantly
contributed to the model. Adding ‘age*race’ (p = .322) and ‘race’ (p = .358) to the model did not
show any significance, which means that there was no interaction between age and race. Please
note that these findings are not reported in Table 18. The equation to predict fatigue severity before
dialysis is the following:
Predicted pre-dialysis fatigue severity = 200.63 – 2.23 (IDWG) – 6.77 (Hb) – 31.75 (Kt/V)
– 0.52 (Age) + 0.22 (CCI)
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Table 18
Regression: Influence of Physiological Factors on PFS Pre-dialysis (n=83)
Predictors

B values

S.E. B.

Constant

200.63

36.29

Beta

t-value

p-value

5.53

<.001

IDWG

-2.23

1.78

-0.13

-1.25

.216

Hemoglobin (Hb)

-6.77

2.18

-0.32

-3.10

.003**

Dialysis adequacy (Kt/V)

-31.75

12.37

-0.27

-2.57

.012*

Age

-0.52

0.19

-0.29

-2.71

.008**

Comorbidity (CCI)

0.22

1.22

0.02

0.18

.855

R2

0.22

Δ R2

0.16
4.28**

F

Note. IDWG=Interdialytic Weight Gain, B=unstandardized coefficients, SE B=standard error of
unstandardized coefficients, R2=Multiple regression coefficient, Δ R2=Adjusted R2
*
p value is significant at .05 level
**
p value is significant at .01 level

Table 19 shows the findings from multiple regression that was done on total raw scores
obtained from PFS post-dialysis. The physiological variables were the independent variables. Only
4% of variance in total scores of fatigue severity was predicted by physiological factors postdialysis. Age was contributing significantly to the model, p = .029. However, the model was not
statistically significant, F = 1.732(5,74), p = .138. The equation to predict fatigue post-dialysis is:
Predicted post-dialysis fatigue severity=153.51- 0.50 (IDWG) – 4.02 (Hb) -20.91 (Kt/V) 0.57 (Age) +0.97 (CCI)
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Table 19
Regression: Influence of Physiological Factors on PFS Post-dialysis (n=80)
Predictors

B

S.E. B.

Beta

t-value

p-value

3.17

.002

values
Constant

153.51

48.32

IDWG

-0.50

2.39

-0.24

-0.21

.837

Hemoglobin (Hb)

-4.02

2.88

0.15

-1.39

.169

Dialysis adequacy (Kt/V)

-20.91

16.72

-0.14

-1.25

.215

Age

-0.57

0.25

-0.25

-2.22

.029*

Comorbidity (CCI)

0.97

1.62

0.06

0.59

.552

R2

0.10

Δ R2

0.04

F

1.73

Note. IDWG=Interdialytic Weight Gain, B=unstandardized coefficients, SE B=standard error of
unstandardized coefficients, R2=Multiple regression coefficient, Δ R2=Adjusted R2
*
p value is significant at .05 level.

Specific Aim 3: Identify the extent to which select situational factors such as living status,
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD
on HD.
The variable ‘race’ was recoded to two categories, ‘African Americans’ and ‘Non-African
Americans’; ‘living status’ to ‘living alone’ versus ‘living with someone’, employment status to
‘working’ and ‘not working.’ The total scores from adding 12 items on PFS are put into four
categories, namely, “no fatigue” with a score of 0 to 10, “mild fatigue” for a score of 11 to 40,
“moderate fatigue” for a score of 41 to 80, “severe fatigue” for a score of 81 to 120.
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Living Status and Fatigue Severity
As seen in Table 20, living status and fatigue severity are significantly associated (p = .003).
As shown in Figure 6, more people living with someone were moderately fatigued compared to
people who lived alone. All the patients who lived alone reported fatigue.
Table 20
Association between Living Status and Fatigue Severity in Pre-dialysis Period (N=86)
Living status
Living with someone
Living alone

No fatigue

Mild fatigue

Moderate fatigue

Severe fatigue

8 (9.3%)

13 (15.1%)

35 (40.7%)

5 (5.8%)

0

14(16.3%)

7 (8.1%)

4 (4.7%)

Note. χ2 = 14.24, d.f.= 3, p = .003*
*p-value is significant

Figure 6. Bar chart: living status by fatigue severity in pre-dialysis
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Table 21 and Figure 7 shows the association between living status and fatigue severity in
the post-dialysis period, and the Chi- square value was not significant at .05 level. People who
lived alone reported similar fatigue severity compared to people who lived with someone postdialysis.
Table 21
Association between Living Status and Fatigue Severity in Post-dialysis Period (n=81)
Living status

No fatigue

Mild fatigue

Moderate fatigue

Living with someone

10(12.3%)

15(18.5%)

19(23.5%)

13(16%)

2(2.5%)

8(9.9%)

7(8.6%)

7(8.6%)

Living alone

Severe fatigue

Note. χ2 =1.62(3), p = .653

Figure 7. Bar chart: living status by fatigue severity in post-dialysis
Employment Status and Fatigue Severity
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As seen in Table 22 and Figure 8, the association between employment status and fatigue
severity in pre-dialysis period was not statistically significant, however, the p-value was trending
towards significance. People who were ‘not working’ reported similar fatigue severity compared
to people who were working ‘pre-dialysis’.
Table 22
Association Between Employment and Fatigue Severity Pre-dialysis (N=86)
Employment

No fatigue

Mild fatigue

Moderate fatigue

Severe fatigue

Not working

7(8.1%)

26(30.2%)

32(37.2%)

9(10.5%)

Working

1(1.2%)

1(1.2%)

10(11.6%)

0

Note. χ2 =7.23(3), p = .065

Figure 8. Bar chart: employment status by fatigue severity pre-dialysis
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As seen in Table 23 and Figure 9, association between employment status and fatigue
severity in post-dialysis period was not statistically significant. People who were ‘not working’
reported similar fatigue severity compared to people who were working post-dialysis. All people
who were ‘working’ reported fatigue in the post-dialysis period, however, not significant.
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Table 23
Association between Employment and Fatigue Severity Post-dialysis (N=81)
Employment
Not working

No fatigue

Mild fatigue

Moderate fatigue

Severe fatigue

12(14.8%)

20(24.7%)

21(25.9%)

17(21%)

0

3(3.7%)

5(6.2%)

3(3.7%)

Working
Note. χ2 =2.63(3), p = .452

Figure 9. Bar chart: employment status by fatigue severity in post-dialysis period
Gender and Fatigue Severity
Table 24 and Figure 10 presents the association between gender and fatigue severity in the
pre-dialysis period, and the chi-square value was not statistically significant. Males and females
reported similar fatigue severity in pre-dialysis period.
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Table 24
Association between Gender and Fatigue Severity Pre-dialysis (N=86)
Gender

No fatigue

Mild fatigue

Moderate fatigue

Severe fatigue

Male

7(8.1%)

15(17.4%)

23(26.7%)

5(5.8%)

Female

1(1.2%)

12(14%)

19(22.1%)

4(4.7%)

Note. χ2 = 3.12(3), p = .372

Figure 10. Bar chart: gender by fatigue severity in pre-dialysis period
Table 25 and Figure 11 presents the association between gender and fatigue severity in the
post-dialysis period, and the Chi-square value was not significant at .05 level. Males and females
reported similar fatigue severity in post-dialysis period.
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Table 25
Association between Gender and Fatigue Severity Post-dialysis (N=81)
Gender

No fatigue

Mild fatigue

Moderate fatigue

Severe fatigue

Male

9(11.1%)

13(16%)

15(18.5%)

9(11.1%)

Female

3(3.7%)

10(12.3%)

11(13.6%)

11(13.6%)

Note. χ2 =2.76(3), p = .429

Figure 11. Bar chart: gender by fatigue severity in post-dialysis period
Race and Fatigue Severity
As seen in Table 26 and Figure 12, the association between race and fatigue severity is not
statistically significant in the pre-dialysis period. African Americans and non-African Americans
reported similar fatigue severity.
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Table 26
Association between Race and Fatigue Severity Pre-dialysis (N=86)
Race

No fatigue

Mild fatigue

Moderate fatigue

Severe fatigue

AA

4(4.7%)

13(15.1%)

21(24.4%)

4(4.7%)

Non-AA

4(4.7%)

14(16.3%)

21(24.4%)

5(5.8%)

Note. χ2 = .1(3), p = .992, AA=African Americans

Figure 12. Bar chart: race by fatigue severity in pre-dialysis period
Table 27 and Figure 13 presents the association between race and fatigue severity in the
post-dialysis period, and the chi-square was not statistically significant at .05 level. African
Americans and Non-African Americans reported similar fatigue severity in the post-dialysis
period.
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Table 27
Test of Association between Race and Fatigue Severity Post-dialysis (N=81)
Race

No fatigue

Mild fatigue

Moderate fatigue

Severe fatigue

AA

6(7.4%)

12(14.8%)

10(12.3%)

12(14.8%)

Non-AA

6(7.4%)

11(13.6%)

16(19.8%)

8(9.9%)

Note. χ2 = 2.21(3), p = .529, AA: African Americans

Figure 13. Bar chart: race by fatigue severity in post-dialysis period
Regression of Situational Factors on Fatigue Severity
The variables ‘race’ was recoded to two categories, ‘African Americans’ and ‘Non-African
Americans’; ‘living status’ to ‘living alone’ versus ‘living with someone’, employment status to
‘working’ and ‘not working.’ The dependent variable, fatigue severity was recoded to two
categories, ‘fatigue absent’ and ‘fatigue present.’ A logistic regression was done to study the
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influence of situational factors such as race, gender, living status and employment status on fatigue
severity (dependent variable). Table 28 presents findings from logistic regression in the predialysis period. The logistic regression model was statistically significant, χ2 = 10.77(4), p = .029.
None of the independent variables such as race, gender, living status and employment status added
significantly to the model, however, gender was trending towards significance. Males were 7.31
times more likely to be fatigued severely compared to females, pre-dialysis.
Table 28
Regression: Influence of Situational Factors on Fatigue Severity Pre-Dialysis
Factors
Race
Living status
Employment status
Gender
R2

B values

B (Exp)

Significance

.44

1.55

.582

-19.6

0

.998

.56

1.75

.628

2

7.31

.073

.255

Note. χ2 = 10.77(4), p = .029

A logistic regression was done to study the influence of situational factors such as race,
gender, living status and employment status on fatigue severity (dependent variable). Table 29
presents findings from logistic regression in the post-dialysis period. The logistic regression model
was not statistically significant, χ2 = 8.84(4), p =.065, but was trending. None of the independent
variables such as race, gender, living status and employment status added significantly to the
model, however, gender was trending. Males were 3.36 times more likely to be fatigued severely
than females in the post-dialysis period. Please note the odds ratios or B(Exp) have reduced from
pre-dialysis to the post-dialysis period.
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Table 29
Regression: Influence of Situational Factors on Fatigue Severity Post-Dialysis
Factors

B values

B (Exp)

Significance

Race

.06

1.07

.924

Living status

-1.2

.3

.157

Employment status

20.04

-

.999

Gender

1.21

3.36

.097

R2

.182

Note. χ2 = 8.84(4), p = .065

Summary
Almost 90% reported fatigue pre-dialysis, and 85% reported fatigue post-dialysis. Based
on different types of fatigue, a total of 90% people reported affective fatigue, 85% had sensory
fatigue, 75% had cognitive fatigue and 89% had behavioral fatigue pre-dialysis. In the post-dialysis
period, 85% had affective fatigue, 94% had sensory fatigue, 82% had cognitive fatigue and 93%
had behavioral fatigue.
Based on the levels of fatigue as categorized by PFS-12, 31.4% were mildly fatigued predialysis, 28.4% were mildly fatigued post-dialysis. Almost 50% were moderately fatigued predialysis, 32% fatigued post-dialysis. And severely fatigued were 10% pre-dialysis, whereas 24%
were severely fatigued post-dialysis.
Based on the frequency of fatigue as defined by PROMIS-fatigue, 44% were fatigued
‘sometimes’ in the past 7 days, and 36% were fatigued ‘often’ and ‘always’ in the past 7 days. The
fatigue severity was higher than the general U.S. population based on PROMIS-fatigue. The
fatigue severity in the current study was higher than patients with cancer and rheumatoid arthritis,
and was lower than patients with heart failure, depression and COPD exacerbation.
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Based on the 6MWT, patients walked significantly less post-dialysis than they did predialysis. Based on PFS-12, the mean fatigue scores increased from pre-dialysis to post-dialysis
period, however, was not statistically significant.
Among the influencing factors, many physiological factors were associated with fatigue
severity. Age was correlated weakly to fatigue severity pre-dialysis and post-dialysis. Hemoglobin
values and dialysis adequacy were correlated with fatigue severity in the pre-dialysis period.
Comorbidities were associated with PROMIS fatigue. From multiple regression, age, dialysis
adequacy and hemoglobin significantly predicted fatigue severity pre-dialysis. After dialysis, only
age significantly predicted fatigue severity.
Among the situational factors, more people living with someone reported fatigue compared
to people who were living alone. From findings of the regression analyses, none of the situational
variables predicted fatigue severity pre-dialysis or post-dialysis. However, gender was trending
towards significance. Males were more likely to be fatigued severely compared to females before
and after dialysis.
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CHAPTER 5: DISCUSSION
The purpose of this study was to examine the severity and trajectory pattern of fatigue and
delineate various physiological and situational factors that may influence fatigue severity in
individuals with CKD Stage G5 on HD. The discussion is according to the aims and research
questions.
This study was done in subjects on hemodialysis treatment. The chronic and frequent
nature of the treatment makes these patients unique, as they come for HD treatment every 2-3 days
per week in an outpatient dialysis clinic. Due to this frequency of visits, the follow-up and
availability of subjects becomes very easy as a researcher. And the volume of patients seen by a
dialysis clinic remains stable for a long period of time, since dialysis is a chronic treatment most
of the times.
This study was conducted in multiple DaVita dialysis sites. DaVita has a chain of dialysis
clinics with supported infrastructure and guidelines for conducting research, that makes ‘gaining
entry’ into the clinic easier. There were no significant differences in the subject population in terms
of age, gender and race. However, there were a few differences between the three sites, such as,
volume of patients being dialyzed at a clinic, volume of patients interested in participating in the
study, and course length that was used for the 6-minute walk test.
This is the first study to report 6MWT results on a dialysis day, before and after dialysis.
Studies conducted in the past have utilized 6MWT to measure physical performance or on a nondialysis day. And therefore, a real-time assessment of physical fatigue before and after dialysis has
been done for the first time.
This study had 55 individuals who performed 6MWT before dialysis and 44 walked after
dialysis. Most patients who gave approval to walk were walking daily either to do chores or for
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work. Most patients were interested or motivated to do the walk test. There were subjects who had
stigma attached to the word “walk” and thought of it as a stress test or physical exertion test. On
explaining further, they agreed. Some individuals were reluctant to walk due to reasons such as
work and transportation. Some individuals walked before dialysis, however, could not walk postdialysis due to feeling sick, pain in legs, feeling dizzy, cramping and tiredness. There were a few
individuals who walked with prosthetic device, tracheostomy, and walkers.
PROMIS-CAT fatigue was used for the first time in dialysis individuals in this study, and
therefore, is a significant contribution to the body of evidence. The measure was easy to administer,
the user requires a registration with the Red Cap software. Patients were able to understand the
questions, and more questions were administered to the individuals by the computer in case
patients did not answer appropriately. The computer itself picks questions from the PROMIS item
bank based on the responses given. However, the number of questions administered varied person
to person which makes analysis difficult. A T-score in the end determines the intensity or severity
of fatigue. The other dimensions such as frequency and duration are measured through individual
questions in the questionnaire, however, the multidimensionality does not get reflected in the end
on analysis, and researcher has to search for questions that could be answering a specific dimension
for analysis purposes. More clarity is needed in this area of PROMIS-CAT fatigue measure.
The PFS-12 was administered to individuals before and after dialysis to measure their
current levels of fatigue for the first time in this study. To our knowledge, previous study that has
utilized PFS used a longer version of the questionnaire with 22-27 items and was administered
post-dialysis only. PFS-12 had excellent reliability in this study and measured various subtypes of
fatigue. We also found a significant inverse weak correlation of PFS-12 with 6-minute walk
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distance post-dialysis. Therefore, PFS-12 could be an excellent measure of examining physical
fatigue as well.
Aim 1: Examine severity and trajectory pattern of fatigue in individuals with Stage G5 CKD
on HD.
Research Question 1a: How severe was the level of sensory, behavioral, cognitive and
affective fatigue before and after dialysis?
In this study, participants reported moderate severity of affective, sensory and behavioral
fatigue, and mild cognitive fatigue. A significant difference was noted before and after dialysis, in
terms of cognitive and sensory fatigue, whereas no significant difference was seen in behavioral
and affective fatigue pre and post-dialysis.
Among the various types of fatigue subscales according to Piper Fatigue Scale, moderate
‘affective fatigue’ scores were reported before and after dialysis session in this study. Almost 90%
patients had affective fatigue pre-dialysis and 85% had affective fatigue post-dialysis. A previous
investigator who did a qualitative study in patients on HD reported ‘affective fatigue’ as an
overarching subtheme in the findings (Lee et al., 2007). However, a before and after dialysis
assessment of fatigue was missing in that study. Thus, our findings confirm findings from Lee
(2007), and add to the evidence of ‘affective fatigue’ being present in the pre-dialysis period.
The present study found moderate ‘sensory fatigue’ scores with a significant increase in
scores post-dialysis compared to pre-dialysis period. Almost 85% had sensory fatigue pre-dialysis
and 94% had sensory fatigue post-dialysis. The ‘sensory fatigue’ subscale in PFS is similar to
‘physical fatigue’ described in qualitative studies by Horrigan (2013) and Lee (2007). During
dialysis, there are fluid shifts and other exchanges of small molecules and ions that happen and
cause physical symptoms. There is a decline in energy and strength (Horigan et al., 2013). Some
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patients described after dialysis, ‘it felt as if life was taken from me’ (Lee et al., 2007). Karakan
(2011) did a quantitative study that has reported ‘sensory fatigue’ in HD subjects after dialysis
treatment. Sensory PFS scores were 21% mild, 37% moderate, and 42% severe in that study
(Karakan et al., 2011). Post-dialysis sensory fatigue was 33.3% mild, 32.1% moderate and 28.4%
severe in our study. Presence of sensory fatigue pre-dialysis has not been studied in the past, and
this study is the first to report the same.
This study found mild ‘cognitive fatigue’ in pre and post-dialysis sessions, with a
significant increase in cognitive fatigue after dialysis. Almost 75% reported cognitive fatigue predialysis and 82% had cognitive fatigue post-dialysis. No other studies have done a comparison of
cognitive fatigue pre and post-dialysis. Lee (2007) described ‘cognitive fatigue’ as an important
domain in her qualitative study on 14 patients on HD and is a decline in cognitive function. Patients
had intentional isolation, regretted lost cognition and tried to cope with cognitive fatigue. Horrigan
(2013) mentioned ‘mental fatigue’ as an overarching subtheme in individuals on dialysis. Patients
in that study had difficulty in remembering names and details they knew for a long time. A low
‘mental fatigue’ score was reported in another quantitative study (Biniaz et al., 2013). Both ‘mental
fatigue’ and ‘cognitive fatigue’ seem to be overlapping in features and needs further investigation.
A weak non-significant correlation was observed between hemoglobin and cognitive fatigue in
this study, that was trending towards significance. Anemia could be a causative factor for cognitive
fatigue or cognitive impairment (Patel, Dasgupta, Tadros, & Baharani, 2016), as evidenced by
Karakan et al (2011). Some theories suggest ‘dialysis disequilibrium’ that leads to cerebral edema,
and causes reduction in cognitive function (Patel et al., 2016). Cognitive fatigue happens due to
low serum glucose, high serum urea and C-reactive protein levels, that leads to cerebral
disintegration and cognitive dysfunction eventually (Karakan et al., 2011). Investigators have
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shown an increase in C-reactive protein levels in 454 individuals on HD with reduced cognitive
function (Watanabe et al., 2016). This study did not examine serum markers and is an area for
further investigation.
Research Question 1b: How frequently did the HD participants describe being fatigued?
This study utilized PROMIS-CAT fatigue in dialysis population for the first time. In
response to the PROMIS question ‘how often did you have to push yourself to get things done
because of your fatigue in the past seven days?’, almost 70% (n = 61) patients said that they had
fatigue ‘often’ or ‘sometimes’ in the past seven days. These responses indicate that participants
are frequently fatigued. There are no previous studies that have reported data on frequency of
fatigue in dialysis population to our knowledge. Dialysis treatment happened 2-3 times in a week,
and this study shows that patients are fatigued before and after dialysis. These findings support
qualitative data from Horigan and Barroso (2016), in which the combination of continuous fatigue
and acute fatigue after dialysis creates a vicious circle of fatigue. Thus, patients are never ‘fatiguefree’ in a week. Before they recover from the past dialysis treatment, it’s time for another dialysis
treatment (Horigan & Barroso, 2016).
Research Question 1c: Did the mean fatigue score differ from US and other chronic disease
populations?
The mean fatigue score was higher and was significantly different from the average
population of U.S., and was significantly higher than individuals with cancer, and rheumatoid
arthritis (Cella et al., 2016). The mean fatigue score in this study was significantly lower than
individuals with congestive heart failure, COPD exacerbation, and major depressive disorder
(Cella et al., 2016).
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The current study had higher mean fatigue scores compared to patients with congestive
heart failure (Cella et al., 2016). Cytokines are responsible for fatigue, cognitive fatigue and
depression (Karshikoff, Sundelin, & Lasselin, 2017; Lasselin & Capuron, 2014). Levels of
cytokines such as C-Reactive Protein are much higher in patients on dialysis and range from 5 to
50 ng/ml, whereas in cardiovascular disease, the levels are much lower and range between 1 to 3
ng/ml (Kovesdy, Joel, & Zadeh, 2017). Based on this finding, one would expect higher fatigue
scores in dialysis patients. However, contrasting findings found in this study could be due to
majority of the subjects were from a younger age group and subjects living with someone.
In cancer, cytokines lead to cytokine-induced sickness behavior, however, an investigator
found that these cytokines are related to physical fatigue and not mental fatigue (de Raaf et al.,
2012). The current study found both types of fatigue, physical and cognitive in patients on dialysis.
Perhaps, the higher fatigue scores in this study are reflective of both types of fatigue present in the
dialysis population. No studies have compared different qualities of fatigue present in cancer, and
therefore to draw a necessary hypothesis is difficult.
Research Question 1d: What was the trajectory of fatigue severity from the pre-dialysis to
the post-dialysis period?
In terms of prevalence, nearly all of the patients (90.7%) in this sample were fatigued predialysis whereas a lesser number, but still a majority of the patients (84.6%) were fatigued postdialysis. The intensity increased in the ‘severe fatigue’ category from 10.5% to 24.1%. However,
no significant difference was observed pre versus post-dialysis. These findings are similar to
Biniaz and colleagues (2013) who reported that all the patients on HD, with a mean age of 61 years
(SD = 12.61 years), complained of fatigue. However, a description of comorbidities is missing in
the study. Other investigators have reported a lower prevalence of fatigue in HD. Zyga and
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colleagues (2015) reported prevalence of fatigue to be 62%, with a mean age of 56 years (Zyga et
al., 2015). Another investigator reported 65% fatigue in patients on HD post-dialysis (Karakan et
al., 2011). However, Karakan and colleagues did not include subjects who had co-morbidities, and
the median age of subjects in that study was 55 years compared to the mean age of 61 years (Mdn
= 63.5 years) in the current study. In this study, majority of the subjects (n = 53) were less than 65
years of age, with no significant difference in fatigue severity between individuals less than and
greater than 65 years of age. Our study found an inverse relation between fatigue severity levels
and age. Therefore, it can be postulated that the high prevalence of fatigue in the current study
could be due to patients with higher comorbidities. Based on Charlson Comorbidity Index, 87%
patients had severe comorbidities in this study.
In this study, most individuals had ‘moderate fatigue’ pre-dialysis. These findings are
similar to Horigan & Barroso (2016) who reported temporal patterns of fatigue after dialysis. In
that study, participants had continuous fatigue even after long hours of rest and sleep. Some
participants who had ‘continuous fatigue’ never returned to a baseline but continued to have
fatigue until the next day when they get started for another hemodialysis session (Horigan &
Barroso, 2016). The same continuous fatigue extends to next day and is captured by pre-dialysis
questionnaire in this study. No other studies have reported pre-dialysis fatigue and needs further
investigation.
Post-dialysis, most individuals reported moderate fatigue in this study. Letchmi (2011)
found 54% of the patients with high level of fatigue and 45.6% experienced a low level of fatigue.
They used Multidimensional Fatigue Inventory that classified subjects to 2 categories of fatigue
(Letchmi et al., 2011). In this study, Piper Fatigue Scale was used that classified subjects to 3
categories, and therefore, the variable findings might be due to different types of fatigue
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instruments used. The findings are contrasting with another investigator findings that utilized Piper
Fatigue Scale and had 43% patients reporting severe fatigue post-dialysis (Karakan et al., 2011).
The mean scores of fatigue increased after dialysis, however, there was no statistical
difference between the mean scores in this study. Interestingly, this is the only study that reports a
comparison of fatigue score before and after dialysis. Only 1 previous study compared ‘nondialysis’ and ‘dialysis day’ fatigue scores, in that there was increased fatigue severity on ‘dialysis
day’ and an increase in fatigue intensity later in evening compared to morning or afternoon time
(Abdel-Kader et al., 2014). Our study confirms these findings that fatigue gets worse later in the
day after dialysis. Other investigators have reported post-dialysis fatigue scores or non-dialysis
day fatigue scores (Horigan & Barroso, 2016; Karakan et al., 2011; Picariello, Moss-Morris,
Macdougall, & Chilcot, 2018). Some investigators do not specifically report the timing of
questionnaire administration in relation to timing of hemodialysis session (Zyga et al., 2015). This
study reiterates the importance of diurnal variations of fatigue in the dialysis population.
Research Question 1e: What was the impact of fatigue on the physical performance of HD
participants pre and post dialysis?
The current study examined motor fatigue using 6MWT and for the first-time patients
performed walk test pre-dialysis and post-dialysis. No falls were reported during the walk in the
study. Most patients completed walk test. Some patients had to lean on the wall to get their balance
back, and some could not complete the walk due to feeling dizzy, breathlessness, pain in legs, back
pain. Some individuals took breaks to rest during the walk and finished the walk at 6 minutes.
In this study, individuals walked significantly further during 6-minute walk test before
dialysis compared to post-dialysis. On an average, patients walked 290 meters before dialysis and
273 meters after dialysis. Two studies were found that examined 6MWT results on patients on HD
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and found that patients walked much further than those in the current study. However, the other
studies did the walk test on non-dialysis days. Results from those studies indicated that patients
walked 400-600 meters (Pajek et al., 2016)and 387.89 meters (Dziubek et al., 2016).
Only one other study was found that conducted the walk test on dialysis day. Results from
that study, 310 meters (Manfredini et al., 2017), are similar to results from the current study. The
current study had subjects do walk-test 10 minutes before and after they were initiated and
terminated on dialysis respectively. The present study adds to the evidence of ranges walked during
6MWT on a dialysis day. A 6MWD of 300 or less indicates a poor prognosis (“ATS Statement,”
2002). Since the distance walked before and after dialysis is less than 300 meters in this study, this
finding suggests that the sample in our study had a poor prognosis. However, a future study with
walk test performed on dialysis and non-dialysis day might provide more information about
prognosis in this population.
Individuals who reported ‘no fatigue’ walked further compared to individuals who
reported ‘fatigue present.’ However, no significant difference was observed before and after
dialysis based on subjective fatigue levels. The number of patients with ‘no fatigue’ was small; 8
pre-dialysis and 12 post-dialysis. No previous studies have compared 6-minute walk distance
(6MWD) with subjective fatigue levels. In this study, a significant correlation was obtained
between total raw score derived from PFS and 6MWD post-dialysis, but the relationship was not
significant pre-dialysis. The correlation between 6-minute walk and subjective fatigue could be
due to the ‘physical fatigue’ described as ‘feelings of being washed out and lifelessness’ presenting
in the post-dialysis period. Since there was no correlation between pre-dialysis PFS and 6MWD,
it could be stated that the pre-dialysis fatigue may not have physical symptoms compared to the
post-dialysis session.
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The mean 6MWD covered was significantly lower in this study when compared to healthy
subjects from seven different countries (Casanova et al., 2011). This finding signifies that subjects
on dialysis have significantly reduced physical functional ability (Roshanravan et al., 2013; Torino
et al., 2014). A review by Kosmadakis and colleagues (2010) suggested decline of physical
activity by 3.4% every month after initiation of dialysis in patients. There is a catabolic state
associated with hemodialysis leading to protein catabolism and degradation, and skeletal muscles
start getting wasted away. The transport of amino acids to the muscle to generate force does not
happen appropriately. Mitochondria, the power house of a cell are not able to metabolize energy
the same way as before. Furthermore, the release of inflammatory markers such as IL-6 lead to a
muscle wasting and affect physical function (Kosmadakis et al., 2010).
Aim 2: Identify the extent to which select physiological factors such as anemia, dialysis
adequacy, inter-dialytic weight gain, co-morbidities, and age influence fatigue severity in
individuals with Stage G5 CKD on HD.
In this study, the correlation between hemoglobin values and fatigue scores was weak and
inverse in the pre-dialysis period and was statistically significant, which means that the higher
hemoglobin levels were associated with lower fatigue scores. Among the physiological factors,
hemoglobin was a significant predictor of fatigue severity pre-dialysis. Please note that the
hemoglobin values were not done on the same day when interviews and fatigue assessment was
done. The dialysis clinic performed hemoglobin checks every two weeks routinely, and in this
current study we collected information about hemoglobin values from the medical records of the
patient.
The relationship between hemoglobin values and fatigue scores in the post-dialysis period
was not statistically significant. Most of the previous studies have reported similar findings. These
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studies did not find a statistical correlation between total fatigue scores and anemia (Biniaz et al.,
2013; Bossola et al., 2018; Chilcot et al., 2016). However, Karakan (2011) found that sensory
fatigue was correlated with hemoglobin levels (Karakan et al., 2011). Weak and lack of
relationship could be due to the erythropoietin therapy treatment that patients on dialysis are
usually on to achieve a target hemoglobin level. Homogeneity of treated hemoglobin values may
be leading to a weak relationship.
The correlation between dialysis adequacy and fatigue severity score was not significant
in the pre or post-dialysis period, however, was trending towards statistical significance. Dialysis
adequacy was a significant predictor of fatigue pre-dialysis. In a study by Bossola and colleagues
(2018), post-dialysis fatigue was not associated with dialysis adequacy indicator, Kt/V. The
present study did not see a relationship, which could be due to all patients being treated to achieve
adequate Kt/V according to the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines.
Also, in the present study, fatigue assessment was done on a different day than the day set for
laboratory blood collection. It could be interesting to see if these relationships would be significant
if laboratory analyses were done on the same day of interview. This is an area for further
exploration. This study had insufficient funding to offset laboratory costs.
In this study, there was no statistically significant difference between the mean interdialytic
weight gains and fatigue severity. Our findings are similar to Bossola and colleagues (2018), who
did not find an association between interdialytic weight gain and post-dialysis fatigue.
No correlation was found between comorbidity scores and fatigue pre and post-dialysis. But,
based on the PROMIS questionnaire, the correlation between pre-dialysis fatigue score and
comorbidity score was statistically significant, which means that higher the comorbidities, the
higher the intensity of fatigue. Contrasting findings have been reported by some investigators, in
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that post dialysis fatigue was not associated with comorbidity (Bossola et al., 2018; Chilcot et al.,
2016). However, Wang and colleagues (2016) reported a significant association between
comorbidity and fatigue scores. Patients who have severe comorbidities might be requiring more
frequent hospital visits and hospitalizations, that might be causing financial and emotional stress
to the individual impacting fatigue severity.
There was a significant but weak and inverse correlation between age and fatigue severity
scores pre and post-dialysis in this study. Age was a significant predictor of fatigue severity before
and after dialysis. Younger age was associated with higher fatigue scores. This is an interesting
finding as most investigators have reported higher fatigue levels in older age groups (Karakan et
al., 2011). The physiological changes that occur in elderly people causes them to be more fatigued
compared to younger patients (Zyga et al., 2015).Some investigators have reported no association
between age and fatigue (Jhamb et al., 2009; Zyga et al., 2015). In the present study, no interaction
was reported between age and race. However, the current study had 36% people who were African
Americans and were less than 65 years of age. Perhaps, young patients probably had some racial
differences that led to greater fatigue levels.
Aim 3: Identify the extent to which select situational factors such as living status,
employment, gender, and race influence fatigue severity in individuals with Stage G5 CKD
on HD.
Pre-dialysis people who ‘lived with someone’ had more fatigue compared to people who
‘lived alone.’ However, post-dialysis fatigue was similar in both the groups. Perhaps, people who
‘lived with someone’ are burdened with care of their spouse and children, and this perception
might be impacting their fatigue levels.
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In terms of employment, people who were ‘not working’ reported similar fatigue severity
compared to people who were ‘working.’ However, in this study there were more people who were
‘retired.’ Perhaps, a study with more subjects who are ‘working’ may yield a significant
association between the two variables. Contrasting findings were reported by Karakan (2011), in
that fatigue score was correlated with employment status (Karakan et al., 2011). Biniaz and
colleagues (2013) reported that employed patients were less fatigued than unemployed, or retired
patients. Employed patients have more physical activity, adequate social relations and may get
support from colleagues and friends (Biniaz et al., 2013).
According to Chi-square analysis, males and females reported similar fatigue severity in
pre and post-dialysis period. In the current study, 26.7% males reported moderate fatigue
compared to 22% females who were moderately fatigued pre-dialysis. Post-dialysis 18.5% males
were moderately fatigued, and 13.6% females were moderately fatigued. However, the Chi-square
was not significant. On performing a logistic regression to study the influence of situational factors
on fatigue severity, none of the situational factors were significant predictors. However, gender
was trending towards significance. Males were more likely to be fatigued severely compared to
females in the pre-dialysis and post-dialysis period. Some investigators have denied any
relationship between fatigue and gender (Biniaz et al., 2013; Zyga et al., 2015) whereas some have
found significant relationship. Most report that women report being more fatigued than men. It has
been suggested that this may be because women express their feelings/illnesses whereas men see
illness as a loss of power (Artom et al., 2014; Zyga et al., 2015). Therefore, fatigue is underreported
by men in many cultures (Biniaz et al., 2013). Perhaps, the culture in U.S. population is different
than other cultures and could be moderating the relationship between fatigue and gender.
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In terms of race, African Americans and non-African Americans reported similar fatigue
severity. Jhamb and colleagues (2009) reported that African Americans had higher energy levels
compared to non-African Americans. Perhaps, African Americans on dialysis are spiritually
stronger and may not perceive their illness as a burden (Jhamb et al., 2009). However, the current
study could not illustrate a relationship between race and fatigue.
Conformation of Findings with Theoretical Framework
This study has confirmed and refuted some of the relationships from theory of unpleasant
symptoms (Lenz & Pugh, 2018). The two constructs that were studied are: Symptoms and
influencing factors. Findings from the current study have been organized into the following
sections.
Symptoms
Fatigue, as a single symptom was examined in patients on chronic dialysis. This study
supports the proposition from TOUS that a ‘symptom has various dimensions.’ This study
examined the types of fatigue, severity of different fatigue types, overall severity and frequency of
fatigue. Based on PROMIS-fatigue, participants had higher fatigue levels compared to the general
U.S. population, patients with cancer and rheumatoid arthritis (Broderick et al., 2013; Cella et al.,
2016). Nearly all of the patients were fatigued pre-dialysis whereas most of the patients were
fatigued post-dialysis. The proportion of patients in the severely fatigued category increased from
10% to 24%. Tiredness was reported by 77% of patients on hemodialysis in a study by Jablonski
(2007) who used TOUS as a framework (Jablonski, 2007). In the current study with regard to the
frequency of fatigue, most patients said they were fatigued ‘sometimes’ and ‘often’ in the past 1
week. Jablonski (2007) reported similar findings in relation to the frequency of fatigue, in that
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muscle weakness was the most ‘frequently occurring’ symptom and was present ‘most’ of the
days.
Different sub-types of fatigue exist such as sensory, affective, behavioral, cognitive and
motor fatigue. These different types describe the quality of fatigue consistent with TOUS. Most
patients on dialysis suffered from ‘affective fatigue’ before and after dialysis, and ‘sensory fatigue’
was more frequent post-dialysis. Very few patients complained of cognitive fatigue. Motor fatigue
causes reduced physical function, and patients walked less far after dialysis than they did predialysis.
Influencing Factors
Factors are classified to physiological and situational factors that influence fatigue and its
dimensions.
Physiological factors. Four from the five physiological factors were associated with
fatigue severity pre-dialysis, whereas one physiological factor was associated with fatigue severity
post-dialysis. Age was correlated weakly to fatigue severity pre and post-dialysis. Age, dialysis
adequacy, and hemoglobin predicted fatigue severity pre-dialysis significantly. After dialysis, age
predicted fatigue severity significantly. Hemoglobin values and dialysis adequacy were correlated
with fatigue severity in the pre-dialysis period. Comorbidities were associated with PROMIS
fatigue pre-dialysis. In summary, our study supports the proposition from TOUS that ‘influencing
factors affect a particular symptom and its dimension’ in pre-dialysis, not in the post-dialysis
period. Mc Cann and Boore (2000) did not find any significant association between physiological
factors such as hemoglobin, dialysis adequacy, other laboratory tests, gender with fatigue severity
in 39 subjects on HD. The subjects however, in that study differed as they had all subjects below
65 years of age. In that study, an interaction was noted between physiological and situational

98
factors (McCann & Boore, 2000). The current study did not find an interaction between
physiological factor, age and situational factor, race. The other major difference to be noted is that
there was no real-time fatigue measurement in that study, and patients were given questionnaires
to be filled at home irrespective to the timing of dialysis. Such a measurement could have recall
bias unlike the current study where we used real-time methods to study fatigue. Almutary and
colleagues (2017) noted that age and comorbidities were important predictors of ‘symptom
experience’ as a part of the structural equation model in patients on dialysis.
Situational factors. Among the situational factors, more people living with someone
reported fatigue pre-dialysis compared to people who were living alone based on Chi-square
analysis. Gender, race, living status and employment were not associated with fatigue pre and post
dialysis based on logistic regression. To summarize, our study did not support TOUS propositions
as confirmed by McCann and Boore (2000). In that study, they did not find association between
situational factors such as marital status, employment status, years on dialysis and fatigue
presence. The influencing factor, gender was dropped from the structural equation model in
another study done on 423 subjects on HD (Almutary, Douglas, & Bonner, 2017). Thus, it could
be stated that situational factors do not play an important role in influencing fatigue severity. To
be noted, most studies in the past have collected information about marital status, and the current
study examined ‘living status’ for the first time in dialysis subjects. Also, we did not have a
powered sample for doing a logistic regression in this study.
From the findings of our study, TOUS was able to describe dimensions of symptom
‘fatigue.’ TOUS provided minimal confirmation in terms of predicting fatigue symptom
dimensions. However, other studies have noticed an important role of ‘psychological factors’ in
predicting fatigue in dialysis (Almutary et al., 2017; McCann & Boore, 2000). The current study
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did not examine ‘psychological factors’ and therefore, a final comment on the predictive ability of
TOUS is not possible at this time. Also, a future study with enough power may be helpful in
commenting on the predictive ability of TOUS.
Clinical Implications
Clinical Practice
This study found a high prevalence of fatigued individuals pre-dialysis and post-dialysis.
Assessment of fatigue is important and must be taught to nurses, doctors and families caring for
individuals with CKD and HD. Subjective questionnaires such as PFS are a great way to assess
fatigue. At the same time, the 6MWT is a safe, and effective way to assess and trend physical or
motor fatigue.
This study found high fatigue levels in individuals less than 65 years of age who lived with
someone. This signifies people who live with someone need to be assessed for fatigue severity.
Social support could be provided to individuals on HD who are burdened with care of spouses and
families. Caregivers and family members can be instructed not to burden the patient on fatigue
days. ‘Psychosocial counselling’ interventions that counsels a patient regarding energy
distribution, improving physical activity, sleep hygiene practices can be helpful in reducing their
fatigue levels (Ju, Strippoli, et al., 2018; Van Der Borg, Schipper, & Abma, 2016).
Physiological factors play a role in increasing fatigue levels. Especially, individuals with
anemia and inadequate dialysis who need to be identified and treated accordingly. Patients with
anemia can be treated with erythropoietin injections whereas for inadequate dialysis patients may
be considered for dialysis with a higher dialysate flow rate (Cha & Min, 2016). Some investigators
suggest lowering the dialysate temperatures also called cold dialysis to improve post-dialysis
fatigue (Sajadi, Gholami, Hekmatpour, Soltani, & Haghverdi, 2016), however this intervention
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needs further exploration (Azar, 2009). Sajadi and colleagues (2016) reported a significant 31%
reduction in fatigue in a group of patients on HD who were cold dialyzed. Nocturnal (Bugeja et
al., 2009) or daily dialysis (Jaber et al., 2010; Ray, 2010) may have effect on post-dialysis fatigue.
Patients on HD were moderately fatigued before and after dialysis, with an increase in
fatigue post-dialysis. Taking rest for few hours before patient comes in for a dialysis session and
after session concludes could be a testable strategy. Some clinicians advise patients to keep a diary
of activities that require most energy, and accordingly prioritizing those activities that are less
energy demanding around the dialysis treatment may be helpful in managing fatigue (Goudsmit,
Nijs, Jason, & Wallman, 2012). Strategies can be discussed with participants on how to cope with
fatigue periods. Brochures and self-help groups based on fatigue assessment could be helpful in
patients with high risk for developing fatigue, which is nearly all patients on HD (Mohamed, 2014).
Improving levels of physical activity (Sheshadri, Kittiskulnam, & Johansen, 2018),
complimentary therapies such as tai-chi (Zhang Y et al., 2013), acupressure (Sabouhi, Kalani,
Valiani, Mortazavi, & Bemanian, 2013), foot reflexology could be considered for patients with
high fatigue levels (Unal & Balci Akpinar, 2016). Cognitive behavior therapy is another treatment
being tested in dialysis population and involves modification of distorted thoughts, emotions and
behavior. This therapy may help in reducing fatigue levels (Picariello, Moss-Morris, Macdougall,
Norton, et al., 2018).
Medications such as levocarnitine, human growth hormone and serum albumin infusion
may help in reducing fatigue in dialysis population through various mechanisms. However, these
medications needs further investigation (Jhamb et al., 2008; Ju, Strippoli, et al., 2018).
Clinical Education
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Based on the findings that there is a high prevalence of fatigue, it is imperative to educate
nurses about fatigue in patients on dialysis. Information can be incorporated from this study in
undergraduate and graduate level curricula. Nurses can be taught through continuing education or
primary education on topics such as measures for fatigue assessment, influencing factors of
fatigue, and use of the 6-minute walk test in fatigue assessment. Educational programs could
include strategies for alleviating fatigue, and the impact of fatigue on health. Content addressing
impact of fatigue on health and quality of life must be included to create awareness among nurses
about the importance of fatigue assessment and alleviation in dialysis population. It is not only
important to educate nurses and staff, but also to provide education to patients and families.
Research Implications
Measures need to be identified that study multidimensional aspects of fatigue. Existing
measures of fatigue are limited by their unidimensionality and scarcity of validating studies. More
research is needed to validate existing multidimensional measures for assessment of fatigue in
individuals on HD. Objective measures such as the 6-minute walk test is an excellent measure to
assess physical fatigue. More research is required to validate the use of 6-minute walk in dialysis
population. A 6MWT conducted on dialysis versus non-dialysis day can provide information about
physical fatigue on non-treatment days. A 6MWT conducted four times a day on a treatment as
well as non-treatment day may be also helpful in getting real-time data about a person’s physical
fatigue levels.
More studies on different patterns of fatigue such as continuous fatigue and acute fatigue,
in dialysis are needed that utilize real-time methods such as 6-minute walk test, and ecological
momentary assessment. Following a patient after dialysis and through the non-dialysis day until
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the person goes for the next dialysis session could open new findings about fatigue and factors that
influence it.
The current study had more retired individuals compared to individuals who were working.
Most of the working individuals were not interested in the study as they had to rush for work after
dialysis finishes and could not wait for study purposes. A working sample may have different
findings on fatigue and could be studied further in a larger group of patients. Utilizing phone-based
applications for fatigue assessment might be another strategy for this group of people. However,
in that case other factors such as literacy level must be considered while using phone-based
application in this population.
This study showed some of the physiological factors predicting fatigue levels. There are
more clinical parameters that this study could not include due to modest funding and grant
timelines. Studies finding relationship with other physiological factors like albumin, C-reactive
protein, and sleep problems are needed.
This study did not study psychological factors such as depression, anxiety and social
support. Psychological factors may significantly predict fatigue in dialysis and requires further
exploration.
Since patients suffer from cognitive, behavioral and affective fatigue, psychological
interventions like Cognitive Behavior Therapy may be a helpful intervention in patients suffering
from fatigue in dialysis. More research is needed in this regard.
The majority of the subjects in this study were retired and had severe comorbidities. The
6-minute walk test could be studied in a type of dialysis population who are employed and has
fewer co-morbidities.
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Strengths of the Study
This study has used the PROMIS measures for fatigue assessment using computer
administration method in Redcap software, thereby contributing towards NIH goal of using this
measure across various diseases. We utilized this measure in a dialysis population that consisted
of retired individuals, who are not usually considered computer-savvy.
The current study utilized PFS-12, a modified version of PFS for the first time in dialysis
population. Studies that have utilized PFS in dialysis administered the measure after dialysis
(Karakan et al., 2011). Our study measured fatigue before and after dialysis.
This study had 6-minute walk test conducted in the pre and post-dialysis sessions, which
provides a real-time assessment of fatigue as opposed to other studies that have performed 6minute walk test on a non-dialysis day or have measured physical performance.
This study reports the reliability of PROMIS-CAT fatigue and PFS-12; that conforms the
robustness of these measures and has a potential to be used in future studies for assessment of
fatigue.
This study has findings from multi-sites with real time assessment of fatigue before and
after dialysis, that increases the generalizability of the findings. Almost all studies on fatigue have
utilized self-report measures in the past. This study uses a combination of self-report and objective
measures like 6-minute walk test that increases the validity of our findings. This study has an
ethnically-diverse powered sample and findings may be attributable to bigger population with
diversity.
Limitations of the Study
Convenience sampling was used and therefore, the findings may not be generalizable to a
bigger population. We could not collect data from individuals who were dropped or declined from
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the study to examine significant differences of subjects based on age, weight gain, and race. More
subjects could be enrolled with greater funding and hiring research assistants from a bigger team
that the present study could not achieve. The laboratory collection was not done on the same day
of interview and walk test due to modest funding. Laboratory collection on the same day may have
resulted in achieving significant findings with physiological factors.
We had a higher consent declination rate from one of the sites, which could be due to the
principal investigator (who obtained consent) being seen an ‘outsider’ by many of the patients.
The consent rates may be higher if a site personnel obtains informed consent from the subjects.
Some of the findings from regression did not achieve significance due to inadequate sample size
in the study based on the post-hoc power analysis. A future study with enough power may be
helpful.
Summary
Fatigue is a ubiquitous symptom in majority of the chronic diseases, and currently one of
the research priorities in NINR. This study examined fatigue in 86 patients on chronic dialysis
from various dialysis centers in Michigan. The multiple dimensions of fatigue were examined
using multidimensional subjective measures such as Piper Fatigue Scale and PROMIS-fatigue,
along with one objective measure, the six-minute walk test. Some of these measures have never
been utilized in the dialysis population. Nearly all the patients had fatigue, with most patients
suffering from affective fatigue pre and post dialysis; and sensory fatigue post-dialysis. This study
examined various physiological and situational factors that influenced fatigue severity in this
dialysis population. Among these factors, dialysis adequacy, age, hemoglobin, comorbidity and
living status were associated with fatigue severity. Thus, this study has advanced knowledge about
the prevalence and dimensions of fatigue, and the underlying factors that influence fatigue in
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dialysis population. A better understanding of symptoms such as fatigue may eventually help in
better management of chronic kidney disease and contribute to a better quality of life in this
population.
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Advisor: Dr. Margaret L. Campbell
Major: Nursing
Degree: Doctor of Philosophy
Background: Fatigue is present in individuals on Hemodialysis (HD). Evidence on fatigue
in HD are limited by focus on unidimensional aspect of fatigue, flawed unidimensional tools, lack
of objective measures, and variability in the correlates of fatigue. Purpose: To examine severity
and trajectory pattern of fatigue; delineate influencing physiological and situational factors predialysis and post-dialysis. Theoretical Framework: The Theory of Unpleasant Symptoms was
used to guide the study. Methodology: A descriptive, correlational, before-after design was
utilized. Measures were Piper Fatigue Scale (PFS)-12, Patient Reported Outcomes Measurement
Information Systems (PROMIS)-Fatigue, Charlson Comorbidity Index and six-minute walk test
(6MWT). Adults, cognitively intact patients on HD were included; patients with limited mobility,
heart issues and abnormal vital signs were excluded for the 6MWT. Results: Sample was 86
participants, 24-89 years old, 58.1% males, and 51.1% non-whites. In terms of prevalence, 90%
of the patients were fatigued pre-dialysis whereas 85% of the patients were fatigued post-dialysis.
Most individuals were moderately fatigued pre-dialysis and most were mildly and moderately
fatigued post-dialysis. The mean scores of fatigue based on PFS-12 increased after dialysis,
however, no statistical difference was observed. In terms of quality of fatigue, high ‘affective
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fatigue’ mean scores were reported before and after dialysis session. An increase in sensory and
cognitive fatigue was observed from pre-dialysis to the post-dialysis period. In terms of
frequency,70% patients said that they had fatigue ‘often’ or ‘sometimes’ in the past 7 days. The
mean PROMIS fatigue score was significantly higher than average U.S. population. Individuals
walked significantly further during 6-minute walk test pre-dialysis than post-dialysis, that indicates
patients are physically fatigued. Fatigue was severe in individuals with low hemoglobin values,
inadequate dialysis, comorbidities, young age group and individuals who lived with someone.
Conclusion: Prevalence of fatigue is higher in dialysis than general population, and fatigue
escalates after dialysis. Therapies that can target sensory, cognitive and physical fatigue may be
helpful in alleviation of fatigue in these patients. A better understanding of fatigue will eventually
help in better management of chronic kidney disease and contribute to a better quality of life in
this population.
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